샘플 요청 목록

 카트 문의
시장보고서
상품코드
2158553

불임 검사 시장

Fertility Testing
발행일: | 리서치사: 구분자 Market Glass, Inc. | 페이지 정보: 영문 476 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



가격
PDF & Excel (Single User License) help
PDF & Excel 보고서를 1명만 이용할 수 있는 라이선스입니다. 파일 내 텍스트의 복사 및 붙여넣기는 가능하지만, 표/그래프 등은 복사할 수 없습니다. 인쇄는 1회 가능하며, 인쇄물의 이용범위는 파일 이용범위와 동일합니다.
US $ 5,850 금액 안내 화살표 ￦ 7,891,000
PDF & Excel (Team License: Up to 10 users) help
PDF & Excel 보고서를 동일 기업 내 최대 10명까지 이용할 수 있는 라이선스입니다. 파일 내 텍스트의 복사 및 붙여넣기가 가능하지만, 표/그래프 등은 복사할 수 없습니다. 인쇄는 이용자 1명당 1회 가능하며, 인쇄물의 이용범위는 파일 이용범위와 동일합니다.
US $ 11,115 금액 안내 화살표 ￦ 14,993,000
PDF & Excel (Global License to Company and its Fully-owned Subsidiaries) help
PDF & Excel 보고서를 동일 기업 및 100% 자회사의 모든 분이 이용하실 수 있는 라이선스입니다. 인쇄는 1인당 1회 가능하며, 인쇄물의 이용범위는 파일 이용범위와 동일합니다.
US $ 17,550 금액 안내 화살표 ￦ 23,673,000
※ 부가세 별도
한글목차
영문목차
※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계 불임 검사 시장은 2032년까지 128억 달러에 달할 것으로 전망됩니다.

2025년 82억 달러로 추정되는 세계 불임 검사 시장은 2025-2032년의 분석 기간 동안 연평균 성장률(CAGR) 6.6%를 기록하며, 2032년까지 128억 달러에 달할 것으로 예측됩니다. 본 보고서에서 분석 대상으로 다루고 있는 부문 중 하나인 ‘배란 예측 검사’는 연평균 성장률(CAGR) 4.8%를 기록하며, 분석 기간이 끝날 때까지 42억 달러에 달할 것으로 전망됩니다. ‘여성 불임 호르몬 검사’ 부문의 성장률은 분석 기간 동안 연평균 성장률(CAGR) 8.4%를 나타낼 것으로 추정됩니다.

미국 시장은 22억 달러로 추산되는 반면, 중국은 연평균 성장률(CAGR) 9.8%를 나타낼 것으로 예측됩니다.

미국의 불임 검사 시장은 2025년에 22억 달러로 추산됩니다. 세계 2위의 경제 규모를 자랑하는 중국은 2025-2032년의 분석 기간 동안 연평균 성장률(CAGR) 9.8%를 기록하며, 2032년까지 시장 규모가 28억 달러에 달할 것으로 예측됩니다. 그 밖의 주목할 만한 지역 시장으로는 일본과 캐나다가 꼽히며, 각각 분석 기간 동안 연평균 성장률(CAGR) 3.4% 및 6.3%를 나타낼 것으로 예측됩니다. 유럽에서는 독일이 연평균 성장률(CAGR) 약 4.2%를 나타낼 것으로 예측됩니다.

세계 불임 검사 시장 - 주요 동향 및 촉진요인 개요

불임 검사는 생식 건강과 가족 계획에 어떤 변화를 가져오고 있는가?

불임 검사는 개인과 부부에게 자신의 생식 능력에 관한 중요한 인사이트를 제공함으로써 생식 건강과 가족 계획을 혁신하고 있습니다. 이를 통해 임신이나 불임 치료에 대해 보다 충분한 정보를 바탕으로 한 의사결정이 가능해집니다. 이러한 검사는 여성의 호르몬 수치와 난소 예비 능력부터 남성의 정자 수와 운동성에 이르기까지, 남녀 양쪽의 생식 능력에 영향을 미치는 다양한 요인을 평가하는 데 도움이 됩니다. 의료 기술의 발전과 불임 치료 서비스의 접근성 향상과 함께, 불임 검사는 더 이상 ‘최후의 수단’으로 간주되지 않고, 임신을 계획 중이거나 임신에 어려움을 겪고 있는 분들에게 적극적인 대책으로 인식되고 있습니다.

불임 검사는 맞춤형 의료라는 광범위한 추세 속에서 필수적인 요소가 되어, 부부가 자신의 불임 상태를 조기에 파악하고 필요에 따라 대책을 마련할 수 있게 되었습니다. 혈액 검사나 호르몬 측정부터 초음파 검사, 정액 검사에 이르기까지, 불임 검사는 생식 건강에 관한 종합적인 평가를 제공합니다. 경력, 교육, 혹은 개인적인 이유로 출산을 미루는 사람들이 늘어남에 따라 불임 평가에 대한 수요는 급증하고 있습니다. 또한, 불임 검사는 점점 더 종합적으로 발전하여 이성애 커플뿐만 아니라, 임신을 위해 불임 치료 지원이 필요한 독신자나 LGBTQ+ 커플에게도 대응하고 있습니다. 기술과 의학이 지속적으로 발전함에 따라, 불임 검사는 개인이나 커플이 부모가 되기를 계획하고 이를 실현하기 위한 중요한 수단으로 부상하고 있습니다.

왜 불임 검사는 생식 건강 상태를 이해하고 가족 계획 결정을 내리는 데 중요한 것일까？

불임 검사는 임신에 영향을 미치는 요인에 대한 중요한 데이터를 제공하므로, 생식 건강을 이해하고 가족 계획 결정을 내리는 데 필수적입니다. 조기 불임 검사는 난소 예비 능력 저하, 배란 불규칙, 정자 질 저하 등 임신 능력에 영향을 미칠 수 있는 문제를 개인이나 커플이 파악하는 데 도움이 됩니다. 이러한 문제를 조기에 진단함으로써, 불임 치료 전문가는 생활 습관 개선부터 불임 치료에 이르기까지 개인 맞춤형 조언을 제공할 수 있으며, 임신 성공 가능성을 높일 수 있습니다. 여성의 경우, 항뮬러관 호르몬(AMH) 검사, 난포 자극 호르몬(FSH) 검사, 초음파 검사 등을 통해 난자의 수와 난소 기능을 평가하고, 여성의 가임 기간 및 잠재적인 생식 능력에 대한 정보를 얻을 수 있습니다.

남성의 경우에도 불임 검사는 마찬가지로 중요합니다. 불임 증례의 약 50%는 남성 요인에 기인하기 때문입니다. 정액 검사는 남성 불임 검사에서 중요한 요소이며, 정자 수, 운동률, 형태를 평가합니다. 정자의 생성이나 기능에 관한 문제를 파악함으로써, 불임 치료 전문의는 생식 성과를 향상시키기 위한 적절한 치료나 생활 습관 개선을 제안할 수 있습니다. 불임 검사는 다낭성 난소 증후군(PCOS), 자궁내막증, 호르몬 불균형 등 생식 능력에 영향을 미칠 수 있는 기저 질환을 발견하는 데에도 매우 중요한 역할을 합니다. 이러한 질환을 조기에 파악함으로써 호르몬 요법이나 수술과 같은 적극적인 조치를 취하여 자연 임신이나 보조생식기술(ART)을 통한 임신 가능성을 높일 수 있습니다.

또한, 불임 검사는 난자나 정자의 동결보존과 같은 생식 능력 보존 방안을 고려하고 있는 개인이나 부부에게 매우 귀중한 정보를 제공합니다. 생식 기능의 건강 상태를 평가함으로써, 개인은 난자나 정자를 언제 동결보존해야 할지에 대해 충분한 정보를 바탕으로 판단을 내릴 수 있으며, 향후 사용을 대비하여 생식 능력을 확실하게 보존할 수 있습니다. 체외수정(IVF)이나 자궁내 인공수정(IUI)과 같은 불임 치료의 맥락에서 불임 검사는 치료 프로토콜의 지침이 되며, 환자 개개인의 생식 프로파일에 맞추어 치료법을 조정함으로써 성공 가능성을 극대화합니다. 불임 검사를 통해 가능해진 이러한 맞춤형 접근 방식은 현대 생식 의학 및 가족 계획의 초석이 되고 있습니다.

생식 의학 전반에 걸쳐, 불임 검사의 적용 범위와 혁신은 어떻게 확대되고 있는가?

불임 검사의 적용 범위와 혁신은 급속히 확대되고 있으며, 생식 건강을 보다 정확하고 편리하며 개인에 맞추어 평가할 수 있는 새로운 도구와 기법이 제공되고 있습니다. 가장 중요한 발전 중 하나는 가정용 불임 검사 키트의 개발입니다. 이를 통해 개인은 병원을 방문하지 않고도 편리하고 사생활을 보호받은 상태에서 자신의 생식 능력 상태를 평가할 수 있게 되었습니다. 여성을 위한 가정용 불임 검사에서는 일반적으로 간단한 혈액이나 타액 샘플을 이용하여 AMH, FSH, 황체형성호르몬(LH) 등 주요 생식 호르몬 수치를 측정하는 호르몬 검사가 이루어집니다. 이러한 검사를 통해 난소 예비 능력, 배란 패턴, 그리고 전반적인 생식 기능의 건강 상태에 대한 정보를 얻을 수 있습니다. 남성을 위해서는 집에서 정자 수와 운동률을 측정할 수 있는 가정용 정액 검사 키트를 이용할 수 있습니다. 이러한 혁신 덕분에, 특히 의료기관에서 검사를 받는 것을 주저하는 분들에게 불임 검사가 점점 더 친숙해지고 있습니다.

또 다른 큰 혁신은 불임 검사에서 인공지능(AI)과 머신러닝을 활용하는 것입니다. 현재 AI를 활용한 도구가 불임 데이터 분석에 사용되고 있으며, 생식 능력과 임신 가능성에 대해 보다 정확한 예측을 제공합니다. 예를 들어, AI는 초음파 영상 진단에 통합되어 난소의 난포를 더 정확하게 평가할 수 있게 되었으며, 한편 머신러닝 알고리즘은 방대한 양의 불임 데이터를 분석하여 불임 치료에 관한 맞춤형 권장 사항을 제공합니다. 이러한 기술 덕분에 불임 검사의 정확도가 향상되고, 임상의가 결과를 해석하기가 쉬워졌기 때문에 더욱 세심한 치료 계획을 수립할 수 있게 되었습니다.

또한 유전자 검사도 불임 평가에서 점점 더 중요한 요소가 되고 있습니다. 임신 전 유전자 검사는 개인이나 부부가 낭포성 섬유증, 테이-삭스병, 겸상적혈구빈혈 등 자녀에게 유전될 가능성이 있는 유전자 변이를 가지고 있는지 파악하는 데 도움이 됩니다. 이 검사는 유전성 질환의 가족력이 있는 분이나 기증자의 난자나 정자를 사용할 예정인 분들에게 특히 유용합니다. 또한, 체외수정(IVF) 과정 중 배아에 대한 유전자 검사, 이른바 착상 전 유전자 검사(PGT)를 통해 염색체 이상을 특정하고 건강한 배아만을 이식할 수 있게 됩니다. 이를 통해 임신 성공률이 향상될 뿐만 아니라, 유산이나 선천성 기형의 위험도 감소됩니다.

기술의 발전으로 인해 기존의 불임 검사법의 정확도와 유효성도 향상되고 있습니다. 예를 들어, 호르몬 검사의 발전으로 인해 불임에 영향을 미칠 가능성이 있는 호르몬 변동을 더 높은 감도로 검출할 수 있게 되었습니다. 컴퓨터를 이용한 정자 형태 분석 등 정자 분석 분야의 혁신을 통해 정자의 질을 보다 상세하고 정확하게 평가할 수 있게 되어, 남성의 생식 능력 상태를 더 명확하게 파악할 수 있게 되었습니다. 또한, 3D 초음파 검사나 자기공명영상법(MRI)과 같은 새로운 영상 진단 기술을 통해 자궁이나 난소의 상태에 대한 보다 상세한 정보를 얻을 수 있게 되어, 불임의 원인이 될 수 있는 자궁근종이나 난관 폐쇄 등의 질환 진단에 도움이 되고 있습니다.

불임 추적 앱과 웨어러블 기기의 보급도 또 다른 확대 추세입니다. 이러한 도구를 통해 개인이 배란 주기나 호르몬 변동을 실시간으로 모니터링할 수 있게 되었습니다. 불임 앱은 기초 체온(BBT), 월경 주기, 호르몬 수치 등의 데이터를 활용해 그 달에 임신 가능성이 가장 높은 날을 예측함으로써, 부부가 최적의 임신 시기에 맞추어 성관계 시기를 잡을 수 있도록 돕습니다. 수면, 체온, 심박 변동을 추적하는 웨어러블 기기도 생식 건강 및 임신 가능 기간에 대해 보다 정확한 정보를 얻기 위해 활용되고 있습니다. 이러한 디지털 헬스 혁신은 생식 건강에 관한 개인 맞춤형 데이터에 기반한 인사이트를 제공함으로써, 개인이 자신의 생식 능력을 주체적으로 관리할 수 있도록 지원하고 있습니다.

불임 검사 시장의 성장을 견인하고 있는 요인은 무엇일까？

불임에 대한 인식 제고, 출산 연령의 늦어짐이라는 추세, 그리고 불임 검사 기술의 발전 등 몇 가지 중요한 요인이 불임 검사 시장의 성장을 이끌고 있습니다. 주요 촉진요인 중 하나는 불임 문제에 대한 세계적인 인식이 높아지고 있다는 점입니다. 불임으로 고민하는 개인이나 부부가 늘어남에 따라 조기 진단과 치료가 더욱 중요시되고 있습니다. 불임 검사는 잠재적인 문제를 파악하고, 자연 임신이나 체외수정(IVF) 등의 보조생식기술을 막론하고 임신을 위한 맞춤형 계획을 세우는 첫걸음이 됩니다. 이러한 인식의 확산으로 인해 의료기관 및 가정에서의 불임 검사 서비스에 대한 수요가 급증하고 있습니다.

출산 연령의 늦어짐이라는 추세 또한 불임 검사 시장의 성장에 기여하는 또 다른 중요한 요인입니다. 가족을 꾸리기 전에 고등 교육이나 경력 목표, 자기 계발을 우선시하는 여성이 늘어남에 따라, 많은 여성이 30대 이후까지 임신을 미루고 있습니다. 그러나 생식 능력은 나이가 들면서 자연스럽게 저하되며, 특히 35세 이후부터는 그 저하가 두드러지기 때문에 더 많은 여성이 자신의 생식 능력을 평가하기 위해 불임 검사를 찾고 있습니다. 불임 검사를 통해 여성은 자신의 생식 건강에 대해, 난자 동결과 같은 생식 기능 보존 옵션을 고려해야 할지, 아니면 조기에 불임 치료를 시작해야 할지 등 충분한 정보를 바탕으로 판단을 내릴 수 있습니다. 이러한 추세가 의료 기관 및 가정용 불임 검사 솔루션 모두에 대한 수요를 견인하고 있습니다.

불임 검사 분야의 기술 발전 또한 시장 성장을 뒷받침하고 있습니다. 호르몬 검사, 유전자 스크리닝, 디지털 헬스 도구 분야의 혁신으로 인해 불임 검사는 더욱 정확하고, 이용하기 쉬우며, 편리해지고 있습니다. 예를 들어, 가정용 불임 검사 키트의 개발로 인해 개인이 병원을 방문하지 않고도 자신의 생식 능력을 평가할 수 있게 되어, 불임 치료에 대한 접근성이 확대되고 있습니다. 또한, 정액 분석 및 영상 진단 기술의 발전으로 불임 전문의의 진단 능력이 향상되어, 남성과 여성의 생식 능력 요인을 보다 정확하게 평가할 수 있게 되었습니다. 이러한 기술이 지속적으로 발전함에 따라, 더욱 개인화되고 효율적인 검사 솔루션을 제공함으로써 불임 검사 시장의 추가적인 성장을 견인할 것으로 기대됩니다.

보다 종합적인 가족 형성 선택지를 추구하는 사회적 변화 또한 불임 검사 시장의 확대에 기여하고 있습니다. 불임 검사는 독신자, LGBTQ+ 커플, 혹은 기증자의 난자나 정자를 이용하여 임신을 희망하는 사람들에 의해 점점 더 많이 이용되고 있습니다. 가족 형태가 다양해지는 가운데, 불임 검사는 개인이나 커플이 생식에 관한 선택지를 고려하는 데 도움이 되는 귀중한 정보를 제공합니다. 이러한 포괄성 덕분에 불임 검사 서비스의 범위가 넓어지면서, 가족을 꾸리려는 더 폭넓은 계층의 사람들에게 더욱 관련성이 높은 서비스가 되고 있습니다.

또한, 특히 젊은 세대 사이에서 생식 건강과 웰빙에 대한 관심이 높아지고 있는 점도 불임 검사 수요를 뒷받침하고 있습니다. 현재는 당장 임신을 계획하고 있지 않더라도, 종합적인 건강 및 웰빙 전략의 일환으로 예방적 불임 검사를 선택하는 사람들이 늘어나고 있습니다. 불임 검사는 호르몬 균형 상태, 생식 건강 및 잠재적 위험에 대한 인사이트를 제공하여, 개인이 미래의 가족 계획에 대해 충분한 정보를 바탕으로 판단을 내릴 수 있도록 돕습니다. 특히, 더 많은 사람들이 초기 단계부터 자신의 생식 건강을 관리하려는 추세 속에서 이러한 예방적 불임 관리가 앞으로도 시장 성장을 지속적으로 견인할 것으로 예측됩니다.

결론적으로, 개인이나 부부가 자신의 생식 건강을 더 깊이 이해하고 가족 계획에 대해 충분한 정보를 바탕으로 판단을 내리려는 가운데, 불임 검사 시장은 눈부신 성장을 이루고 있습니다. 불임 검사 기술의 발전, 불임에 대한 인식 제고, 그리고 맞춤형 헬스케어의 부상으로 인해 불임 검사는 현대 생식 의학에서 필수적인 요소로 자리 잡고 있습니다.

부문:

검사 유형(배란 예측 검사, 여성 생식 호르몬 검사, 남성 생식 기능 검사, 기타 검사), 검체(소변 검체, 타액 검체, 혈액 검체, 정액 검체), 용도(여성 생식 기능 검사, 남성 생식 기능 검사), 최종 용도(가정 간호, 병원, 불임 치료 클리닉, 기타)

주요 기업

  • AdvaCare Pharma
  • Ava Science Inc.
  • Babystart
  • Church &Dwight Co., Inc.
  • Fairhaven Health LLC
  • Fertility Focus Ltd
  • Geratherm Medical AG
  • Hilin Life Products
  • SPD Swiss Precision Diagnostics GmbH
  • TaiDoc Technology Corporation
  • UEBE Medical GmbH
  • Valley Electronics AG

해당 분야의 전문가 관점을 바탕으로 합니다. 산업계, 기업, 학계에 걸친 분야 전문가들의 관점을 반영하여, 기존에 발표된 조사 결과 이상의 맥락을 더하고 있습니다.

시장의 초기 신호를 포착합니다 - 기존의 2차 조사에 완전히 반영되기 전에, 전문가 간의 대화, 기업의 동향, 시장과 관련된 논의를 통해 드러나는 변화를 추적합니다.

광범위하고 검증된 정보 기반을 활용합니다-컨퍼런스 세션, 기조 연설, 패널 토론, 블로그, 기업 공시 정보, 연차 보고서, 기관 간행물 및 기타 검증된 정보원에서 얻은 인사이트를 통합하고 있습니다.

신호와 전략적 시장 방향성을 연결합니다 - 이러한 관점을 통합하여 시장이 어디로 향하고 있는지, 그 움직임을 주도하는 요인은 무엇인지, 그리고 전략에 있어 가장 중요할 가능성이 있는 동향은 무엇인지 파악합니다.

상세한 기업 정보를 제공합니다 - 시장 수준의 분석에 그치지 않고, 경쟁 환경에 참여하며 그 형성에 기여하고 있는 기업을 상세하게 검증합니다.

주요 지역 시장 점유율을 면밀히 검토합니다 - 단일 세계 시장 점유율 수치만으로는 전체적인 상황을 파악하기 어렵습니다. 경쟁 구도는 지역에 따라 크게 다를 수 있습니다. 분석상 관련성이 있는 경우, Market Glass의 보고서는 각 시장의 구조와 동향에 맞추어 상세도를 조정하여 주요 지역 시장 점유율 분석을 심층적으로 다룹니다.

목차

제1장 조사 방법론

제2장 요약

  • 시장 개요
  • 주요 기업
  • 시장 동향 및 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 스페인
  • 러시아
  • 기타 유럽
  • 아시아태평양
  • 호주
  • 인도
  • 한국
  • 기타 아시아태평양
  • 라틴아메리카
  • 아르헨티나
  • 브라질
  • 멕시코
  • 기타 라틴아메리카
  • 중동
  • 이란
  • 이스라엘
  • 사우디아라비아
  • 아랍에미리트
  • 기타 중동
  • 아프리카

제4장 경쟁사

목차

제1장 조사 방법

제2장 주요 요약

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 스페인
  • 러시아
  • 기타 유럽
  • 아시아태평양
  • 호주
  • 인도
  • 한국
  • 기타 아시아태평양
  • 라틴아메리카
  • 아르헨티나
  • 브라질
  • 멕시코
  • 기타 라틴아메리카
  • 중동
  • 이란
  • 이스라엘
  • 사우디아라비아
  • 아랍에미리트
  • 기타 중동
  • 아프리카

제4장 경쟁

LSH

Global Fertility Testing Market to Reach US$12.8 Billion by 2032

The global market for Fertility Testing estimated at US$8.2 Billion in the year 2025, is expected to reach US$12.8 Billion by 2032, growing at a CAGR of 6.6% over the analysis period 2025-2032. Ovulation Prediction Test Type, one of the segments analyzed in the report, is expected to record a 4.8% CAGR and reach US$4.2 Billion by the end of the analysis period. Growth in the Female Fertility Hormone Test Type segment is estimated at 8.4% CAGR over the analysis period.

The U.S. Market is Estimated at US$2.2 Billion While China is Forecast to Grow at 9.8% CAGR

The Fertility Testing market in the U.S. is estimated at US$2.2 Billion in the year 2025. China, the world's second largest economy, is forecast to reach a projected market size of US$2.8 Billion by the year 2032 trailing a CAGR of 9.8% over the analysis period 2025-2032. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.4% and 6.3% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.2% CAGR.

Global Fertility Testing Market - Key Trends and Drivers Summarized

How Is Fertility Testing Revolutionizing Reproductive Health and Family Planning?

Fertility testing is transforming reproductive health and family planning by providing individuals and couples with critical insights into their reproductive potential, allowing for more informed decision-making about conception and fertility treatments. These tests help assess various factors affecting both male and female fertility, from hormone levels and ovarian reserve in women to sperm count and motility in men. With advancements in medical technology and greater accessibility to fertility services, fertility testing is no longer seen as a last resort but rather as a proactive measure for those planning to conceive or facing difficulties in doing so.

Fertility testing has become a vital part of the broader trend towards personalized healthcare, enabling couples to understand their fertility status earlier and take action when necessary. From blood tests and hormone assays to ultrasounds and sperm analysis, fertility testing offers a comprehensive evaluation of reproductive health. As more people delay childbearing due to career, education, or personal reasons, the demand for fertility assessments has surged. In addition, fertility testing is becoming increasingly inclusive, serving not only heterosexual couples but also single individuals and LGBTQ+ couples who may need fertility assistance to conceive. As technology and medical science continue to evolve, fertility testing is emerging as a critical tool in helping individuals and couples plan for and achieve parenthood.

Why Is Fertility Testing Critical for Understanding Reproductive Health and Guiding Family Planning Decisions?

Fertility testing is critical for understanding reproductive health and guiding family planning decisions because it provides essential data on factors that influence conception. Early fertility assessments help individuals and couples identify potential issues that may impact their ability to conceive, such as low ovarian reserve, irregular ovulation, or poor sperm quality. By diagnosing these issues early, fertility specialists can offer personalized recommendations, from lifestyle changes to fertility treatments, which increase the chances of a successful pregnancy. For women, tests like the Anti-Mullerian Hormone (AMH) test, follicle-stimulating hormone (FSH) test, and ultrasound imaging help evaluate egg quantity and ovarian function, offering insight into a woman’s reproductive window and potential fertility.

For men, fertility testing is equally important, as male factors account for nearly 50% of infertility cases. Semen analysis is a key component of male fertility testing, assessing sperm count, motility, and morphology. By identifying issues with sperm production or function, fertility specialists can recommend appropriate treatments or lifestyle modifications to improve reproductive outcomes. Fertility testing also plays a crucial role in detecting underlying medical conditions that may affect fertility, such as polycystic ovary syndrome (PCOS), endometriosis, or hormonal imbalances. Understanding these conditions early on allows individuals to take proactive steps, such as hormone therapy or surgery, to improve their chances of conceiving naturally or through assisted reproductive technologies (ART).

Additionally, fertility testing provides invaluable information for individuals and couples pursuing fertility preservation options, such as egg or sperm freezing. By assessing fertility health, individuals can make informed decisions about when to freeze their eggs or sperm, ensuring they preserve their reproductive potential for future use. In the context of fertility treatments like IVF or intrauterine insemination (IUI), fertility testing guides treatment protocols, optimizing the chances of success by tailoring interventions to the patient’s unique reproductive profile. This personalized approach, enabled by fertility testing, makes it a cornerstone of modern reproductive medicine and family planning.

What Are the Expanding Applications and Innovations in Fertility Testing Across Reproductive Health?

The applications and innovations in fertility testing are rapidly expanding, offering new tools and methods to assess reproductive health with greater accuracy, convenience, and personalization. One of the most significant advancements is the development of home-based fertility tests, which provide a convenient and private way for individuals to assess their fertility status without visiting a clinic. At-home fertility tests for women typically involve hormone tests that measure levels of key reproductive hormones, such as AMH, FSH, and luteinizing hormone (LH), using a simple blood or saliva sample. These tests offer insights into ovarian reserve, ovulation patterns, and overall fertility health. For men, home semen analysis kits are available, allowing them to measure sperm count and motility from the comfort of their homes. These innovations are making fertility testing more accessible, particularly for those who may be hesitant to seek clinical assessments.

Another major innovation is the use of artificial intelligence (AI) and machine learning in fertility testing. AI-powered tools are now being used to analyze fertility data, offering more accurate predictions about fertility potential and the likelihood of conception. For example, AI is being integrated into ultrasound imaging to assess ovarian follicles more precisely, while machine learning algorithms can analyze vast amounts of fertility data to offer personalized recommendations for fertility treatments. These technologies are improving the accuracy of fertility tests and making it easier for clinicians to interpret results, allowing for more tailored treatment plans.

Genetic testing is also becoming a growing component of fertility assessments. Preconception genetic testing helps individuals or couples understand if they carry genetic mutations that could be passed on to their children, such as cystic fibrosis, Tay-Sachs disease, or sickle cell anemia. This testing is particularly valuable for individuals with a family history of genetic disorders or those planning to use donor eggs or sperm. Additionally, genetic testing of embryos during IVF, known as preimplantation genetic testing (PGT), can identify chromosomal abnormalities, ensuring that only healthy embryos are implanted. This not only improves the chances of a successful pregnancy but also reduces the risk of miscarriage or birth defects.

Technological advancements have also improved the accuracy and effectiveness of traditional fertility testing methods. For instance, advancements in hormone testing now allow for more sensitive detection of hormone fluctuations that could affect fertility. Innovations in sperm analysis, such as computer-aided sperm morphology analysis, provide more detailed and accurate assessments of sperm quality, giving a clearer picture of male fertility health. Additionally, new imaging technologies, such as 3D ultrasound and magnetic resonance imaging (MRI), offer more detailed insights into uterine and ovarian health, helping to diagnose conditions like fibroids or blocked fallopian tubes that could affect fertility.

The rise of fertility tracking apps and wearables is another growing trend, with these tools allowing individuals to monitor their ovulation cycles and hormonal fluctuations in real time. Fertility apps use data like basal body temperature (BBT), menstrual cycles, and hormone levels to predict the most fertile days of the month, making it easier for couples to time intercourse for optimal conception. Wearable devices that track sleep, temperature, and heart rate variability are also being used to provide more accurate insights into reproductive health and fertility windows. These digital health innovations are empowering individuals to take control of their fertility by providing personalized, data-driven insights into their reproductive health.

What Factors Are Driving the Growth of the Fertility Testing Market?

Several key factors are driving the growth of the fertility testing market, including the rising awareness of infertility, the trend of delayed childbearing, and advancements in fertility testing technologies. One of the primary drivers is the growing global awareness of infertility issues. As more individuals and couples struggle with infertility, there is a greater emphasis on early diagnosis and treatment. Fertility testing provides the first step in identifying potential problems and creating a personalized plan for conception, whether through natural methods or assisted reproductive technologies like IVF. This increased awareness has led to a surge in demand for fertility testing services, both in clinical settings and at home.

The trend of delayed childbearing is another significant factor contributing to the growth of the fertility testing market. With more women choosing to pursue higher education, career goals, and personal development before starting a family, many are waiting until their 30s or later to conceive. However, fertility naturally declines with age, particularly after the age of 35, leading more women to seek fertility testing to assess their reproductive potential. Fertility testing allows women to make informed decisions about their reproductive health, including whether to pursue fertility preservation options like egg freezing or begin fertility treatments sooner rather than later. This trend is driving demand for both clinical and at-home fertility testing solutions.

Technological advancements in fertility testing are also fueling market growth. Innovations in hormone testing, genetic screening, and digital health tools are making fertility testing more accurate, accessible, and convenient. For example, the development of at-home fertility testing kits has made it easier for individuals to assess their fertility without visiting a clinic, expanding access to fertility care. Additionally, advancements in sperm analysis and imaging technologies are improving the diagnostic capabilities of fertility specialists, allowing for more precise assessments of male and female fertility factors. As these technologies continue to evolve, they are expected to drive further growth in the fertility testing market by offering more personalized and efficient testing solutions.

Societal shifts toward more inclusive family-building options are also contributing to the expansion of the fertility testing market. Fertility testing is increasingly being used by single individuals, LGBTQ+ couples, and those seeking to use donor eggs or sperm to conceive. As family structures become more diverse, fertility testing provides valuable information to help individuals and couples navigate their reproductive options. This inclusivity is broadening the scope of fertility testing services, making them more relevant to a wider range of people seeking to start families.

Moreover, the growing emphasis on reproductive health and wellness, particularly among younger generations, is driving demand for fertility testing. Many individuals are now opting for proactive fertility assessments, even if they are not immediately planning to conceive, as part of their overall health and wellness strategy. Fertility testing offers insights into hormonal balance, reproductive health, and potential risks, allowing individuals to make informed decisions about their future family planning. This proactive approach to fertility is expected to continue driving growth in the market, particularly as more people seek to take control of their reproductive health early on.

In conclusion, the fertility testing market is experiencing significant growth as individuals and couples seek to better understand their reproductive health and make informed decisions about family planning. With advancements in fertility testing technologies, growing awareness of infertility, and the rise of personalized healthcare, fertility testing is becoming an integral part of modern reproductive care.

SCOPE OF STUDY:

The report analyzes the Fertility Testing market by the following Segments, and Geographic Regions/Countries:

Segments:

Test Type (Ovulation Prediction Test Type, Female Fertility Hormone Test Type, Male Fertility Test Type, Other Test Types); Sample (Urine-based Sample, Saliva-based Sample, Blood-based Sample, Semen-based Sample); Application (Female Fertility Testing Application, Male Fertility Testing Application); End-Use (Home Care Settings End-Use, Hospitals End-Use, Fertility Clinics End-Use, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

SELECT PLAYERS -

  • AdvaCare Pharma
  • Ava Science Inc.
  • Babystart
  • Church & Dwight Co., Inc.
  • Fairhaven Health LLC
  • Fertility Focus Ltd
  • Geratherm Medical AG
  • Hilin Life Products
  • SPD Swiss Precision Diagnostics GmbH
  • TaiDoc Technology Corporation
  • UEBE Medical GmbH
  • Valley Electronics AG

WHAT SETS THIS REPORT APART FROM OTHERS?

Grounded in Domain Expert Perspectives - Incorporates perspectives emerging from domain experts across industry, enterprise and academia, adding context beyond conventional published research.

Captures Early Market Signals - Tracks shifts emerging through expert conversations, company activity and market-relevant discussions before they are fully reflected in traditional secondary research.

Draws From a Broad, Validated Intelligence Base - Brings together insights from conference sessions, keynotes, panel discussions, blogs, corporate disclosures, annual reports, institutional publications and other validated sources.

Connects Signals With Strategic Market Direction - Synthesizes these perspectives to identify where the market is moving, what is driving that movement and which developments are likely to matter most for strategy.

Provides In-Depth Company Intelligence - Extends beyond market-level analysis to examine the companies participating in and shaping the competitive environment.

Market Share Is Examined Where It Matters - A single global market share figure rarely tells the full story. Competitive structures can vary significantly across geographies. Where analytically relevant, Market Glass reports extend market share analysis into major regions with the level of detail tailored to the structure and dynamics of each market.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Trade Shocks, Uncertainty, and the Structural Rewiring of the Global Economy
    • How Trump's Tariffs Impact the Market? The Big Question on Everyone's Mind
    • Fertility Testing - Global Key Competitors Percentage Market Share in 2026 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for 41 Players Worldwide in 2026 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Awareness and Prevalence of Fertility Issues Fueling Demand for Fertility Testing
    • Technological Advancements in Home Fertility Testing Kits Increasing Accessibility
    • Growing Use of Fertility Testing by Younger Populations for Preconception Planning
    • Market Trends Toward Integrating Fertility Tests with Digital Health Platforms
    • Impact of Lifestyle Changes and Environmental Factors on Fertility Rates
    • Technological Innovations in Non-invasive Saliva-based and Wearable Fertility Monitors
    • Global Expansion of Fertility Clinics Offering Comprehensive Testing Services
    • Market Response to Increasing Use of Telehealth for Fertility Consultations
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Fertility Testing Market Analysis of Annual Sales in US$ Million for Years 2020 through 2032
    • TABLE 2: World Recent Past, Current & Future Analysis for Fertility Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
    • TABLE 3: World Historic Review for Fertility Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 4: World 13-Year Perspective for Fertility Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2020, 2026 & 2032
    • TABLE 5: World Recent Past, Current & Future Analysis for Ovulation Prediction Test Type by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
    • TABLE 6: World Historic Review for Ovulation Prediction Test Type by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 7: World 13-Year Perspective for Ovulation Prediction Test Type by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
    • TABLE 8: World Recent Past, Current & Future Analysis for Female Fertility Hormone Test Type by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
    • TABLE 9: World Historic Review for Female Fertility Hormone Test Type by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 10: World 13-Year Perspective for Female Fertility Hormone Test Type by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
    • TABLE 11: World Recent Past, Current & Future Analysis for Male Fertility Test Type by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
    • TABLE 12: World Historic Review for Male Fertility Test Type by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 13: World 13-Year Perspective for Male Fertility Test Type by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
    • TABLE 14: World Recent Past, Current & Future Analysis for Other Test Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
    • TABLE 15: World Historic Review for Other Test Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 16: World 13-Year Perspective for Other Test Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
    • TABLE 17: World Recent Past, Current & Future Analysis for Urine-based Sample by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
    • TABLE 18: World Historic Review for Urine-based Sample by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 19: World 13-Year Perspective for Urine-based Sample by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
    • TABLE 20: World Recent Past, Current & Future Analysis for Saliva-based Sample by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
    • TABLE 21: World Historic Review for Saliva-based Sample by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 22: World 13-Year Perspective for Saliva-based Sample by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
    • TABLE 23: World Recent Past, Current & Future Analysis for Blood-based Sample by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
    • TABLE 24: World Historic Review for Blood-based Sample by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 25: World 13-Year Perspective for Blood-based Sample by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
    • TABLE 26: World Recent Past, Current & Future Analysis for Semen-based Sample by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
    • TABLE 27: World Historic Review for Semen-based Sample by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 28: World 13-Year Perspective for Semen-based Sample by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
    • TABLE 29: World Recent Past, Current & Future Analysis for Female Fertility Testing Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
    • TABLE 30: World Historic Review for Female Fertility Testing Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 31: World 13-Year Perspective for Female Fertility Testing Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
    • TABLE 32: World Recent Past, Current & Future Analysis for Male Fertility Testing Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
    • TABLE 33: World Historic Review for Male Fertility Testing Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 34: World 13-Year Perspective for Male Fertility Testing Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
    • TABLE 35: World Recent Past, Current & Future Analysis for Home Care Settings End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
    • TABLE 36: World Historic Review for Home Care Settings End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 37: World 13-Year Perspective for Home Care Settings End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
    • TABLE 38: World Recent Past, Current & Future Analysis for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
    • TABLE 39: World Historic Review for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 40: World 13-Year Perspective for Hospitals End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
    • TABLE 41: World Recent Past, Current & Future Analysis for Fertility Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
    • TABLE 42: World Historic Review for Fertility Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 43: World 13-Year Perspective for Fertility Clinics End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
    • TABLE 44: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
    • TABLE 45: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 46: World 13-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032

III. MARKET ANALYSIS

  • UNITED STATES
    • Fertility Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2026 (E)
    • TABLE 47: USA Recent Past, Current & Future Analysis for Fertility Testing by Application - Female Fertility Testing Application and Male Fertility Testing Application - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 48: USA Historic Review for Fertility Testing by Application - Female Fertility Testing Application and Male Fertility Testing Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 49: USA 13-Year Perspective for Fertility Testing by Application - Percentage Breakdown of Value Sales for Female Fertility Testing Application and Male Fertility Testing Application for the Years 2020, 2026 & 2032
    • TABLE 50: USA Recent Past, Current & Future Analysis for Fertility Testing by End-Use - Home Care Settings End-Use, Hospitals End-Use, Fertility Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 51: USA Historic Review for Fertility Testing by End-Use - Home Care Settings End-Use, Hospitals End-Use, Fertility Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 52: USA 13-Year Perspective for Fertility Testing by End-Use - Percentage Breakdown of Value Sales for Home Care Settings End-Use, Hospitals End-Use, Fertility Clinics End-Use and Other End-Uses for the Years 2020, 2026 & 2032
    • TABLE 53: USA Recent Past, Current & Future Analysis for Fertility Testing by Test Type - Ovulation Prediction Test Type, Female Fertility Hormone Test Type, Male Fertility Test Type and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 54: USA Historic Review for Fertility Testing by Test Type - Ovulation Prediction Test Type, Female Fertility Hormone Test Type, Male Fertility Test Type and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 55: USA 13-Year Perspective for Fertility Testing by Test Type - Percentage Breakdown of Value Sales for Ovulation Prediction Test Type, Female Fertility Hormone Test Type, Male Fertility Test Type and Other Test Types for the Years 2020, 2026 & 2032
    • TABLE 56: USA Recent Past, Current & Future Analysis for Fertility Testing by Sample - Urine-based Sample, Saliva-based Sample, Blood-based Sample and Semen-based Sample - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 57: USA Historic Review for Fertility Testing by Sample - Urine-based Sample, Saliva-based Sample, Blood-based Sample and Semen-based Sample Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 58: USA 13-Year Perspective for Fertility Testing by Sample - Percentage Breakdown of Value Sales for Urine-based Sample, Saliva-based Sample, Blood-based Sample and Semen-based Sample for the Years 2020, 2026 & 2032
  • CANADA
    • TABLE 59: Canada Recent Past, Current & Future Analysis for Fertility Testing by Application - Female Fertility Testing Application and Male Fertility Testing Application - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 60: Canada Historic Review for Fertility Testing by Application - Female Fertility Testing Application and Male Fertility Testing Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 61: Canada 13-Year Perspective for Fertility Testing by Application - Percentage Breakdown of Value Sales for Female Fertility Testing Application and Male Fertility Testing Application for the Years 2020, 2026 & 2032
    • TABLE 62: Canada Recent Past, Current & Future Analysis for Fertility Testing by End-Use - Home Care Settings End-Use, Hospitals End-Use, Fertility Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 63: Canada Historic Review for Fertility Testing by End-Use - Home Care Settings End-Use, Hospitals End-Use, Fertility Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 64: Canada 13-Year Perspective for Fertility Testing by End-Use - Percentage Breakdown of Value Sales for Home Care Settings End-Use, Hospitals End-Use, Fertility Clinics End-Use and Other End-Uses for the Years 2020, 2026 & 2032
    • TABLE 65: Canada Recent Past, Current & Future Analysis for Fertility Testing by Test Type - Ovulation Prediction Test Type, Female Fertility Hormone Test Type, Male Fertility Test Type and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 66: Canada Historic Review for Fertility Testing by Test Type - Ovulation Prediction Test Type, Female Fertility Hormone Test Type, Male Fertility Test Type and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 67: Canada 13-Year Perspective for Fertility Testing by Test Type - Percentage Breakdown of Value Sales for Ovulation Prediction Test Type, Female Fertility Hormone Test Type, Male Fertility Test Type and Other Test Types for the Years 2020, 2026 & 2032
    • TABLE 68: Canada Recent Past, Current & Future Analysis for Fertility Testing by Sample - Urine-based Sample, Saliva-based Sample, Blood-based Sample and Semen-based Sample - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 69: Canada Historic Review for Fertility Testing by Sample - Urine-based Sample, Saliva-based Sample, Blood-based Sample and Semen-based Sample Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 70: Canada 13-Year Perspective for Fertility Testing by Sample - Percentage Breakdown of Value Sales for Urine-based Sample, Saliva-based Sample, Blood-based Sample and Semen-based Sample for the Years 2020, 2026 & 2032
  • JAPAN
    • Fertility Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2026 (E)
    • TABLE 71: Japan Recent Past, Current & Future Analysis for Fertility Testing by Application - Female Fertility Testing Application and Male Fertility Testing Application - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 72: Japan Historic Review for Fertility Testing by Application - Female Fertility Testing Application and Male Fertility Testing Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 73: Japan 13-Year Perspective for Fertility Testing by Application - Percentage Breakdown of Value Sales for Female Fertility Testing Application and Male Fertility Testing Application for the Years 2020, 2026 & 2032
    • TABLE 74: Japan Recent Past, Current & Future Analysis for Fertility Testing by End-Use - Home Care Settings End-Use, Hospitals End-Use, Fertility Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 75: Japan Historic Review for Fertility Testing by End-Use - Home Care Settings End-Use, Hospitals End-Use, Fertility Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 76: Japan 13-Year Perspective for Fertility Testing by End-Use - Percentage Breakdown of Value Sales for Home Care Settings End-Use, Hospitals End-Use, Fertility Clinics End-Use and Other End-Uses for the Years 2020, 2026 & 2032
    • TABLE 77: Japan Recent Past, Current & Future Analysis for Fertility Testing by Test Type - Ovulation Prediction Test Type, Female Fertility Hormone Test Type, Male Fertility Test Type and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 78: Japan Historic Review for Fertility Testing by Test Type - Ovulation Prediction Test Type, Female Fertility Hormone Test Type, Male Fertility Test Type and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 79: Japan 13-Year Perspective for Fertility Testing by Test Type - Percentage Breakdown of Value Sales for Ovulation Prediction Test Type, Female Fertility Hormone Test Type, Male Fertility Test Type and Other Test Types for the Years 2020, 2026 & 2032
    • TABLE 80: Japan Recent Past, Current & Future Analysis for Fertility Testing by Sample - Urine-based Sample, Saliva-based Sample, Blood-based Sample and Semen-based Sample - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 81: Japan Historic Review for Fertility Testing by Sample - Urine-based Sample, Saliva-based Sample, Blood-based Sample and Semen-based Sample Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 82: Japan 13-Year Perspective for Fertility Testing by Sample - Percentage Breakdown of Value Sales for Urine-based Sample, Saliva-based Sample, Blood-based Sample and Semen-based Sample for the Years 2020, 2026 & 2032
  • CHINA
    • Fertility Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2026 (E)
    • TABLE 83: China Recent Past, Current & Future Analysis for Fertility Testing by Application - Female Fertility Testing Application and Male Fertility Testing Application - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 84: China Historic Review for Fertility Testing by Application - Female Fertility Testing Application and Male Fertility Testing Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 85: China 13-Year Perspective for Fertility Testing by Application - Percentage Breakdown of Value Sales for Female Fertility Testing Application and Male Fertility Testing Application for the Years 2020, 2026 & 2032
    • TABLE 86: China Recent Past, Current & Future Analysis for Fertility Testing by End-Use - Home Care Settings End-Use, Hospitals End-Use, Fertility Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 87: China Historic Review for Fertility Testing by End-Use - Home Care Settings End-Use, Hospitals End-Use, Fertility Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 88: China 13-Year Perspective for Fertility Testing by End-Use - Percentage Breakdown of Value Sales for Home Care Settings End-Use, Hospitals End-Use, Fertility Clinics End-Use and Other End-Uses for the Years 2020, 2026 & 2032
    • TABLE 89: China Recent Past, Current & Future Analysis for Fertility Testing by Test Type - Ovulation Prediction Test Type, Female Fertility Hormone Test Type, Male Fertility Test Type and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 90: China Historic Review for Fertility Testing by Test Type - Ovulation Prediction Test Type, Female Fertility Hormone Test Type, Male Fertility Test Type and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 91: China 13-Year Perspective for Fertility Testing by Test Type - Percentage Breakdown of Value Sales for Ovulation Prediction Test Type, Female Fertility Hormone Test Type, Male Fertility Test Type and Other Test Types for the Years 2020, 2026 & 2032
    • TABLE 92: China Recent Past, Current & Future Analysis for Fertility Testing by Sample - Urine-based Sample, Saliva-based Sample, Blood-based Sample and Semen-based Sample - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 93: China Historic Review for Fertility Testing by Sample - Urine-based Sample, Saliva-based Sample, Blood-based Sample and Semen-based Sample Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 94: China 13-Year Perspective for Fertility Testing by Sample - Percentage Breakdown of Value Sales for Urine-based Sample, Saliva-based Sample, Blood-based Sample and Semen-based Sample for the Years 2020, 2026 & 2032
  • EUROPE
    • Fertility Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2026 (E)
    • TABLE 95: Europe Recent Past, Current & Future Analysis for Fertility Testing by Application - Female Fertility Testing Application and Male Fertility Testing Application - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 96: Europe Historic Review for Fertility Testing by Application - Female Fertility Testing Application and Male Fertility Testing Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 97: Europe 13-Year Perspective for Fertility Testing by Application - Percentage Breakdown of Value Sales for Female Fertility Testing Application and Male Fertility Testing Application for the Years 2020, 2026 & 2032
    • TABLE 98: Europe Recent Past, Current & Future Analysis for Fertility Testing by End-Use - Home Care Settings End-Use, Hospitals End-Use, Fertility Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 99: Europe Historic Review for Fertility Testing by End-Use - Home Care Settings End-Use, Hospitals End-Use, Fertility Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 100: Europe 13-Year Perspective for Fertility Testing by End-Use - Percentage Breakdown of Value Sales for Home Care Settings End-Use, Hospitals End-Use, Fertility Clinics End-Use and Other End-Uses for the Years 2020, 2026 & 2032
    • TABLE 101: Europe Recent Past, Current & Future Analysis for Fertility Testing by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
    • TABLE 102: Europe Historic Review for Fertility Testing by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 103: Europe 13-Year Perspective for Fertility Testing by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2020, 2026 & 2032
    • TABLE 104: Europe Recent Past, Current & Future Analysis for Fertility Testing by Test Type - Ovulation Prediction Test Type, Female Fertility Hormone Test Type, Male Fertility Test Type and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 105: Europe Historic Review for Fertility Testing by Test Type - Ovulation Prediction Test Type, Female Fertility Hormone Test Type, Male Fertility Test Type and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 106: Europe 13-Year Perspective for Fertility Testing by Test Type - Percentage Breakdown of Value Sales for Ovulation Prediction Test Type, Female Fertility Hormone Test Type, Male Fertility Test Type and Other Test Types for the Years 2020, 2026 & 2032
    • TABLE 107: Europe Recent Past, Current & Future Analysis for Fertility Testing by Sample - Urine-based Sample, Saliva-based Sample, Blood-based Sample and Semen-based Sample - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 108: Europe Historic Review for Fertility Testing by Sample - Urine-based Sample, Saliva-based Sample, Blood-based Sample and Semen-based Sample Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 109: Europe 13-Year Perspective for Fertility Testing by Sample - Percentage Breakdown of Value Sales for Urine-based Sample, Saliva-based Sample, Blood-based Sample and Semen-based Sample for the Years 2020, 2026 & 2032
  • FRANCE
    • Fertility Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2026 (E)
    • TABLE 110: France Recent Past, Current & Future Analysis for Fertility Testing by Application - Female Fertility Testing Application and Male Fertility Testing Application - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 111: France Historic Review for Fertility Testing by Application - Female Fertility Testing Application and Male Fertility Testing Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 112: France 13-Year Perspective for Fertility Testing by Application - Percentage Breakdown of Value Sales for Female Fertility Testing Application and Male Fertility Testing Application for the Years 2020, 2026 & 2032
    • TABLE 113: France Recent Past, Current & Future Analysis for Fertility Testing by End-Use - Home Care Settings End-Use, Hospitals End-Use, Fertility Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 114: France Historic Review for Fertility Testing by End-Use - Home Care Settings End-Use, Hospitals End-Use, Fertility Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 115: France 13-Year Perspective for Fertility Testing by End-Use - Percentage Breakdown of Value Sales for Home Care Settings End-Use, Hospitals End-Use, Fertility Clinics End-Use and Other End-Uses for the Years 2020, 2026 & 2032
    • TABLE 116: France Recent Past, Current & Future Analysis for Fertility Testing by Test Type - Ovulation Prediction Test Type, Female Fertility Hormone Test Type, Male Fertility Test Type and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 117: France Historic Review for Fertility Testing by Test Type - Ovulation Prediction Test Type, Female Fertility Hormone Test Type, Male Fertility Test Type and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 118: France 13-Year Perspective for Fertility Testing by Test Type - Percentage Breakdown of Value Sales for Ovulation Prediction Test Type, Female Fertility Hormone Test Type, Male Fertility Test Type and Other Test Types for the Years 2020, 2026 & 2032
    • TABLE 119: France Recent Past, Current & Future Analysis for Fertility Testing by Sample - Urine-based Sample, Saliva-based Sample, Blood-based Sample and Semen-based Sample - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 120: France Historic Review for Fertility Testing by Sample - Urine-based Sample, Saliva-based Sample, Blood-based Sample and Semen-based Sample Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 121: France 13-Year Perspective for Fertility Testing by Sample - Percentage Breakdown of Value Sales for Urine-based Sample, Saliva-based Sample, Blood-based Sample and Semen-based Sample for the Years 2020, 2026 & 2032
  • GERMANY
    • Fertility Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2026 (E)
    • TABLE 122: Germany Recent Past, Current & Future Analysis for Fertility Testing by Application - Female Fertility Testing Application and Male Fertility Testing Application - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 123: Germany Historic Review for Fertility Testing by Application - Female Fertility Testing Application and Male Fertility Testing Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 124: Germany 13-Year Perspective for Fertility Testing by Application - Percentage Breakdown of Value Sales for Female Fertility Testing Application and Male Fertility Testing Application for the Years 2020, 2026 & 2032
    • TABLE 125: Germany Recent Past, Current & Future Analysis for Fertility Testing by End-Use - Home Care Settings End-Use, Hospitals End-Use, Fertility Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 126: Germany Historic Review for Fertility Testing by End-Use - Home Care Settings End-Use, Hospitals End-Use, Fertility Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 127: Germany 13-Year Perspective for Fertility Testing by End-Use - Percentage Breakdown of Value Sales for Home Care Settings End-Use, Hospitals End-Use, Fertility Clinics End-Use and Other End-Uses for the Years 2020, 2026 & 2032
    • TABLE 128: Germany Recent Past, Current & Future Analysis for Fertility Testing by Test Type - Ovulation Prediction Test Type, Female Fertility Hormone Test Type, Male Fertility Test Type and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 129: Germany Historic Review for Fertility Testing by Test Type - Ovulation Prediction Test Type, Female Fertility Hormone Test Type, Male Fertility Test Type and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 130: Germany 13-Year Perspective for Fertility Testing by Test Type - Percentage Breakdown of Value Sales for Ovulation Prediction Test Type, Female Fertility Hormone Test Type, Male Fertility Test Type and Other Test Types for the Years 2020, 2026 & 2032
    • TABLE 131: Germany Recent Past, Current & Future Analysis for Fertility Testing by Sample - Urine-based Sample, Saliva-based Sample, Blood-based Sample and Semen-based Sample - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 132: Germany Historic Review for Fertility Testing by Sample - Urine-based Sample, Saliva-based Sample, Blood-based Sample and Semen-based Sample Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 133: Germany 13-Year Perspective for Fertility Testing by Sample - Percentage Breakdown of Value Sales for Urine-based Sample, Saliva-based Sample, Blood-based Sample and Semen-based Sample for the Years 2020, 2026 & 2032
  • ITALY
    • TABLE 134: Italy Recent Past, Current & Future Analysis for Fertility Testing by Application - Female Fertility Testing Application and Male Fertility Testing Application - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 135: Italy Historic Review for Fertility Testing by Application - Female Fertility Testing Application and Male Fertility Testing Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 136: Italy 13-Year Perspective for Fertility Testing by Application - Percentage Breakdown of Value Sales for Female Fertility Testing Application and Male Fertility Testing Application for the Years 2020, 2026 & 2032
    • TABLE 137: Italy Recent Past, Current & Future Analysis for Fertility Testing by End-Use - Home Care Settings End-Use, Hospitals End-Use, Fertility Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 138: Italy Historic Review for Fertility Testing by End-Use - Home Care Settings End-Use, Hospitals End-Use, Fertility Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 139: Italy 13-Year Perspective for Fertility Testing by End-Use - Percentage Breakdown of Value Sales for Home Care Settings End-Use, Hospitals End-Use, Fertility Clinics End-Use and Other End-Uses for the Years 2020, 2026 & 2032
    • TABLE 140: Italy Recent Past, Current & Future Analysis for Fertility Testing by Test Type - Ovulation Prediction Test Type, Female Fertility Hormone Test Type, Male Fertility Test Type and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 141: Italy Historic Review for Fertility Testing by Test Type - Ovulation Prediction Test Type, Female Fertility Hormone Test Type, Male Fertility Test Type and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 142: Italy 13-Year Perspective for Fertility Testing by Test Type - Percentage Breakdown of Value Sales for Ovulation Prediction Test Type, Female Fertility Hormone Test Type, Male Fertility Test Type and Other Test Types for the Years 2020, 2026 & 2032
    • TABLE 143: Italy Recent Past, Current & Future Analysis for Fertility Testing by Sample - Urine-based Sample, Saliva-based Sample, Blood-based Sample and Semen-based Sample - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 144: Italy Historic Review for Fertility Testing by Sample - Urine-based Sample, Saliva-based Sample, Blood-based Sample and Semen-based Sample Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 145: Italy 13-Year Perspective for Fertility Testing by Sample - Percentage Breakdown of Value Sales for Urine-based Sample, Saliva-based Sample, Blood-based Sample and Semen-based Sample for the Years 2020, 2026 & 2032
  • UNITED KINGDOM
    • Fertility Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2026 (E)
    • TABLE 146: UK Recent Past, Current & Future Analysis for Fertility Testing by Application - Female Fertility Testing Application and Male Fertility Testing Application - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 147: UK Historic Review for Fertility Testing by Application - Female Fertility Testing Application and Male Fertility Testing Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 148: UK 13-Year Perspective for Fertility Testing by Application - Percentage Breakdown of Value Sales for Female Fertility Testing Application and Male Fertility Testing Application for the Years 2020, 2026 & 2032
    • TABLE 149: UK Recent Past, Current & Future Analysis for Fertility Testing by End-Use - Home Care Settings End-Use, Hospitals End-Use, Fertility Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 150: UK Historic Review for Fertility Testing by End-Use - Home Care Settings End-Use, Hospitals End-Use, Fertility Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 151: UK 13-Year Perspective for Fertility Testing by End-Use - Percentage Breakdown of Value Sales for Home Care Settings End-Use, Hospitals End-Use, Fertility Clinics End-Use and Other End-Uses for the Years 2020, 2026 & 2032
    • TABLE 152: UK Recent Past, Current & Future Analysis for Fertility Testing by Test Type - Ovulation Prediction Test Type, Female Fertility Hormone Test Type, Male Fertility Test Type and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 153: UK Historic Review for Fertility Testing by Test Type - Ovulation Prediction Test Type, Female Fertility Hormone Test Type, Male Fertility Test Type and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 154: UK 13-Year Perspective for Fertility Testing by Test Type - Percentage Breakdown of Value Sales for Ovulation Prediction Test Type, Female Fertility Hormone Test Type, Male Fertility Test Type and Other Test Types for the Years 2020, 2026 & 2032
    • TABLE 155: UK Recent Past, Current & Future Analysis for Fertility Testing by Sample - Urine-based Sample, Saliva-based Sample, Blood-based Sample and Semen-based Sample - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 156: UK Historic Review for Fertility Testing by Sample - Urine-based Sample, Saliva-based Sample, Blood-based Sample and Semen-based Sample Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 157: UK 13-Year Perspective for Fertility Testing by Sample - Percentage Breakdown of Value Sales for Urine-based Sample, Saliva-based Sample, Blood-based Sample and Semen-based Sample for the Years 2020, 2026 & 2032
  • SPAIN
    • TABLE 158: Spain Recent Past, Current & Future Analysis for Fertility Testing by Application - Female Fertility Testing Application and Male Fertility Testing Application - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 159: Spain Historic Review for Fertility Testing by Application - Female Fertility Testing Application and Male Fertility Testing Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 160: Spain 13-Year Perspective for Fertility Testing by Application - Percentage Breakdown of Value Sales for Female Fertility Testing Application and Male Fertility Testing Application for the Years 2020, 2026 & 2032
    • TABLE 161: Spain Recent Past, Current & Future Analysis for Fertility Testing by End-Use - Home Care Settings End-Use, Hospitals End-Use, Fertility Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 162: Spain Historic Review for Fertility Testing by End-Use - Home Care Settings End-Use, Hospitals End-Use, Fertility Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 163: Spain 13-Year Perspective for Fertility Testing by End-Use - Percentage Breakdown of Value Sales for Home Care Settings End-Use, Hospitals End-Use, Fertility Clinics End-Use and Other End-Uses for the Years 2020, 2026 & 2032
    • TABLE 164: Spain Recent Past, Current & Future Analysis for Fertility Testing by Test Type - Ovulation Prediction Test Type, Female Fertility Hormone Test Type, Male Fertility Test Type and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 165: Spain Historic Review for Fertility Testing by Test Type - Ovulation Prediction Test Type, Female Fertility Hormone Test Type, Male Fertility Test Type and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 166: Spain 13-Year Perspective for Fertility Testing by Test Type - Percentage Breakdown of Value Sales for Ovulation Prediction Test Type, Female Fertility Hormone Test Type, Male Fertility Test Type and Other Test Types for the Years 2020, 2026 & 2032
    • TABLE 167: Spain Recent Past, Current & Future Analysis for Fertility Testing by Sample - Urine-based Sample, Saliva-based Sample, Blood-based Sample and Semen-based Sample - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 168: Spain Historic Review for Fertility Testing by Sample - Urine-based Sample, Saliva-based Sample, Blood-based Sample and Semen-based Sample Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 169: Spain 13-Year Perspective for Fertility Testing by Sample - Percentage Breakdown of Value Sales for Urine-based Sample, Saliva-based Sample, Blood-based Sample and Semen-based Sample for the Years 2020, 2026 & 2032
  • RUSSIA
    • TABLE 170: Russia Recent Past, Current & Future Analysis for Fertility Testing by Application - Female Fertility Testing Application and Male Fertility Testing Application - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 171: Russia Historic Review for Fertility Testing by Application - Female Fertility Testing Application and Male Fertility Testing Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 172: Russia 13-Year Perspective for Fertility Testing by Application - Percentage Breakdown of Value Sales for Female Fertility Testing Application and Male Fertility Testing Application for the Years 2020, 2026 & 2032
    • TABLE 173: Russia Recent Past, Current & Future Analysis for Fertility Testing by End-Use - Home Care Settings End-Use, Hospitals End-Use, Fertility Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 174: Russia Historic Review for Fertility Testing by End-Use - Home Care Settings End-Use, Hospitals End-Use, Fertility Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 175: Russia 13-Year Perspective for Fertility Testing by End-Use - Percentage Breakdown of Value Sales for Home Care Settings End-Use, Hospitals End-Use, Fertility Clinics End-Use and Other End-Uses for the Years 2020, 2026 & 2032
    • TABLE 176: Russia Recent Past, Current & Future Analysis for Fertility Testing by Test Type - Ovulation Prediction Test Type, Female Fertility Hormone Test Type, Male Fertility Test Type and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 177: Russia Historic Review for Fertility Testing by Test Type - Ovulation Prediction Test Type, Female Fertility Hormone Test Type, Male Fertility Test Type and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 178: Russia 13-Year Perspective for Fertility Testing by Test Type - Percentage Breakdown of Value Sales for Ovulation Prediction Test Type, Female Fertility Hormone Test Type, Male Fertility Test Type and Other Test Types for the Years 2020, 2026 & 2032
    • TABLE 179: Russia Recent Past, Current & Future Analysis for Fertility Testing by Sample - Urine-based Sample, Saliva-based Sample, Blood-based Sample and Semen-based Sample - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 180: Russia Historic Review for Fertility Testing by Sample - Urine-based Sample, Saliva-based Sample, Blood-based Sample and Semen-based Sample Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 181: Russia 13-Year Perspective for Fertility Testing by Sample - Percentage Breakdown of Value Sales for Urine-based Sample, Saliva-based Sample, Blood-based Sample and Semen-based Sample for the Years 2020, 2026 & 2032
  • REST OF EUROPE
    • TABLE 182: Rest of Europe Recent Past, Current & Future Analysis for Fertility Testing by Application - Female Fertility Testing Application and Male Fertility Testing Application - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 183: Rest of Europe Historic Review for Fertility Testing by Application - Female Fertility Testing Application and Male Fertility Testing Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 184: Rest of Europe 13-Year Perspective for Fertility Testing by Application - Percentage Breakdown of Value Sales for Female Fertility Testing Application and Male Fertility Testing Application for the Years 2020, 2026 & 2032
    • TABLE 185: Rest of Europe Recent Past, Current & Future Analysis for Fertility Testing by End-Use - Home Care Settings End-Use, Hospitals End-Use, Fertility Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 186: Rest of Europe Historic Review for Fertility Testing by End-Use - Home Care Settings End-Use, Hospitals End-Use, Fertility Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 187: Rest of Europe 13-Year Perspective for Fertility Testing by End-Use - Percentage Breakdown of Value Sales for Home Care Settings End-Use, Hospitals End-Use, Fertility Clinics End-Use and Other End-Uses for the Years 2020, 2026 & 2032
    • TABLE 188: Rest of Europe Recent Past, Current & Future Analysis for Fertility Testing by Test Type - Ovulation Prediction Test Type, Female Fertility Hormone Test Type, Male Fertility Test Type and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 189: Rest of Europe Historic Review for Fertility Testing by Test Type - Ovulation Prediction Test Type, Female Fertility Hormone Test Type, Male Fertility Test Type and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 190: Rest of Europe 13-Year Perspective for Fertility Testing by Test Type - Percentage Breakdown of Value Sales for Ovulation Prediction Test Type, Female Fertility Hormone Test Type, Male Fertility Test Type and Other Test Types for the Years 2020, 2026 & 2032
    • TABLE 191: Rest of Europe Recent Past, Current & Future Analysis for Fertility Testing by Sample - Urine-based Sample, Saliva-based Sample, Blood-based Sample and Semen-based Sample - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 192: Rest of Europe Historic Review for Fertility Testing by Sample - Urine-based Sample, Saliva-based Sample, Blood-based Sample and Semen-based Sample Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 193: Rest of Europe 13-Year Perspective for Fertility Testing by Sample - Percentage Breakdown of Value Sales for Urine-based Sample, Saliva-based Sample, Blood-based Sample and Semen-based Sample for the Years 2020, 2026 & 2032
  • ASIA-PACIFIC
    • Fertility Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2026 (E)
    • TABLE 194: Asia-Pacific Recent Past, Current & Future Analysis for Fertility Testing by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
    • TABLE 195: Asia-Pacific Historic Review for Fertility Testing by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 196: Asia-Pacific 13-Year Perspective for Fertility Testing by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2020, 2026 & 2032
    • TABLE 197: Asia-Pacific Recent Past, Current & Future Analysis for Fertility Testing by Test Type - Ovulation Prediction Test Type, Female Fertility Hormone Test Type, Male Fertility Test Type and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 198: Asia-Pacific Historic Review for Fertility Testing by Test Type - Ovulation Prediction Test Type, Female Fertility Hormone Test Type, Male Fertility Test Type and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 199: Asia-Pacific 13-Year Perspective for Fertility Testing by Test Type - Percentage Breakdown of Value Sales for Ovulation Prediction Test Type, Female Fertility Hormone Test Type, Male Fertility Test Type and Other Test Types for the Years 2020, 2026 & 2032
    • TABLE 200: Asia-Pacific Recent Past, Current & Future Analysis for Fertility Testing by Sample - Urine-based Sample, Saliva-based Sample, Blood-based Sample and Semen-based Sample - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 201: Asia-Pacific Historic Review for Fertility Testing by Sample - Urine-based Sample, Saliva-based Sample, Blood-based Sample and Semen-based Sample Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 202: Asia-Pacific 13-Year Perspective for Fertility Testing by Sample - Percentage Breakdown of Value Sales for Urine-based Sample, Saliva-based Sample, Blood-based Sample and Semen-based Sample for the Years 2020, 2026 & 2032
    • TABLE 203: Asia-Pacific Recent Past, Current & Future Analysis for Fertility Testing by Application - Female Fertility Testing Application and Male Fertility Testing Application - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 204: Asia-Pacific Historic Review for Fertility Testing by Application - Female Fertility Testing Application and Male Fertility Testing Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 205: Asia-Pacific 13-Year Perspective for Fertility Testing by Application - Percentage Breakdown of Value Sales for Female Fertility Testing Application and Male Fertility Testing Application for the Years 2020, 2026 & 2032
    • TABLE 206: Asia-Pacific Recent Past, Current & Future Analysis for Fertility Testing by End-Use - Home Care Settings End-Use, Hospitals End-Use, Fertility Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 207: Asia-Pacific Historic Review for Fertility Testing by End-Use - Home Care Settings End-Use, Hospitals End-Use, Fertility Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 208: Asia-Pacific 13-Year Perspective for Fertility Testing by End-Use - Percentage Breakdown of Value Sales for Home Care Settings End-Use, Hospitals End-Use, Fertility Clinics End-Use and Other End-Uses for the Years 2020, 2026 & 2032
  • AUSTRALIA
    • Fertility Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2026 (E)
    • TABLE 209: Australia Recent Past, Current & Future Analysis for Fertility Testing by Test Type - Ovulation Prediction Test Type, Female Fertility Hormone Test Type, Male Fertility Test Type and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 210: Australia Historic Review for Fertility Testing by Test Type - Ovulation Prediction Test Type, Female Fertility Hormone Test Type, Male Fertility Test Type and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 211: Australia 13-Year Perspective for Fertility Testing by Test Type - Percentage Breakdown of Value Sales for Ovulation Prediction Test Type, Female Fertility Hormone Test Type, Male Fertility Test Type and Other Test Types for the Years 2020, 2026 & 2032
    • TABLE 212: Australia Recent Past, Current & Future Analysis for Fertility Testing by Sample - Urine-based Sample, Saliva-based Sample, Blood-based Sample and Semen-based Sample - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 213: Australia Historic Review for Fertility Testing by Sample - Urine-based Sample, Saliva-based Sample, Blood-based Sample and Semen-based Sample Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 214: Australia 13-Year Perspective for Fertility Testing by Sample - Percentage Breakdown of Value Sales for Urine-based Sample, Saliva-based Sample, Blood-based Sample and Semen-based Sample for the Years 2020, 2026 & 2032
    • TABLE 215: Australia Recent Past, Current & Future Analysis for Fertility Testing by Application - Female Fertility Testing Application and Male Fertility Testing Application - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 216: Australia Historic Review for Fertility Testing by Application - Female Fertility Testing Application and Male Fertility Testing Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 217: Australia 13-Year Perspective for Fertility Testing by Application - Percentage Breakdown of Value Sales for Female Fertility Testing Application and Male Fertility Testing Application for the Years 2020, 2026 & 2032
    • TABLE 218: Australia Recent Past, Current & Future Analysis for Fertility Testing by End-Use - Home Care Settings End-Use, Hospitals End-Use, Fertility Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 219: Australia Historic Review for Fertility Testing by End-Use - Home Care Settings End-Use, Hospitals End-Use, Fertility Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 220: Australia 13-Year Perspective for Fertility Testing by End-Use - Percentage Breakdown of Value Sales for Home Care Settings End-Use, Hospitals End-Use, Fertility Clinics End-Use and Other End-Uses for the Years 2020, 2026 & 2032
  • INDIA
    • Fertility Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2026 (E)
    • TABLE 221: India Recent Past, Current & Future Analysis for Fertility Testing by Test Type - Ovulation Prediction Test Type, Female Fertility Hormone Test Type, Male Fertility Test Type and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 222: India Historic Review for Fertility Testing by Test Type - Ovulation Prediction Test Type, Female Fertility Hormone Test Type, Male Fertility Test Type and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 223: India 13-Year Perspective for Fertility Testing by Test Type - Percentage Breakdown of Value Sales for Ovulation Prediction Test Type, Female Fertility Hormone Test Type, Male Fertility Test Type and Other Test Types for the Years 2020, 2026 & 2032
    • TABLE 224: India Recent Past, Current & Future Analysis for Fertility Testing by Sample - Urine-based Sample, Saliva-based Sample, Blood-based Sample and Semen-based Sample - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 225: India Historic Review for Fertility Testing by Sample - Urine-based Sample, Saliva-based Sample, Blood-based Sample and Semen-based Sample Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 226: India 13-Year Perspective for Fertility Testing by Sample - Percentage Breakdown of Value Sales for Urine-based Sample, Saliva-based Sample, Blood-based Sample and Semen-based Sample for the Years 2020, 2026 & 2032
    • TABLE 227: India Recent Past, Current & Future Analysis for Fertility Testing by Application - Female Fertility Testing Application and Male Fertility Testing Application - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 228: India Historic Review for Fertility Testing by Application - Female Fertility Testing Application and Male Fertility Testing Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 229: India 13-Year Perspective for Fertility Testing by Application - Percentage Breakdown of Value Sales for Female Fertility Testing Application and Male Fertility Testing Application for the Years 2020, 2026 & 2032
    • TABLE 230: India Recent Past, Current & Future Analysis for Fertility Testing by End-Use - Home Care Settings End-Use, Hospitals End-Use, Fertility Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 231: India Historic Review for Fertility Testing by End-Use - Home Care Settings End-Use, Hospitals End-Use, Fertility Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 232: India 13-Year Perspective for Fertility Testing by End-Use - Percentage Breakdown of Value Sales for Home Care Settings End-Use, Hospitals End-Use, Fertility Clinics End-Use and Other End-Uses for the Years 2020, 2026 & 2032
  • SOUTH KOREA
    • TABLE 233: South Korea Recent Past, Current & Future Analysis for Fertility Testing by Test Type - Ovulation Prediction Test Type, Female Fertility Hormone Test Type, Male Fertility Test Type and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 234: South Korea Historic Review for Fertility Testing by Test Type - Ovulation Prediction Test Type, Female Fertility Hormone Test Type, Male Fertility Test Type and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 235: South Korea 13-Year Perspective for Fertility Testing by Test Type - Percentage Breakdown of Value Sales for Ovulation Prediction Test Type, Female Fertility Hormone Test Type, Male Fertility Test Type and Other Test Types for the Years 2020, 2026 & 2032
    • TABLE 236: South Korea Recent Past, Current & Future Analysis for Fertility Testing by Sample - Urine-based Sample, Saliva-based Sample, Blood-based Sample and Semen-based Sample - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 237: South Korea Historic Review for Fertility Testing by Sample - Urine-based Sample, Saliva-based Sample, Blood-based Sample and Semen-based Sample Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 238: South Korea 13-Year Perspective for Fertility Testing by Sample - Percentage Breakdown of Value Sales for Urine-based Sample, Saliva-based Sample, Blood-based Sample and Semen-based Sample for the Years 2020, 2026 & 2032
    • TABLE 239: South Korea Recent Past, Current & Future Analysis for Fertility Testing by Application - Female Fertility Testing Application and Male Fertility Testing Application - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 240: South Korea Historic Review for Fertility Testing by Application - Female Fertility Testing Application and Male Fertility Testing Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 241: South Korea 13-Year Perspective for Fertility Testing by Application - Percentage Breakdown of Value Sales for Female Fertility Testing Application and Male Fertility Testing Application for the Years 2020, 2026 & 2032
    • TABLE 242: South Korea Recent Past, Current & Future Analysis for Fertility Testing by End-Use - Home Care Settings End-Use, Hospitals End-Use, Fertility Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 243: South Korea Historic Review for Fertility Testing by End-Use - Home Care Settings End-Use, Hospitals End-Use, Fertility Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 244: South Korea 13-Year Perspective for Fertility Testing by End-Use - Percentage Breakdown of Value Sales for Home Care Settings End-Use, Hospitals End-Use, Fertility Clinics End-Use and Other End-Uses for the Years 2020, 2026 & 2032
  • REST OF ASIA-PACIFIC
    • TABLE 245: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Fertility Testing by Test Type - Ovulation Prediction Test Type, Female Fertility Hormone Test Type, Male Fertility Test Type and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 246: Rest of Asia-Pacific Historic Review for Fertility Testing by Test Type - Ovulation Prediction Test Type, Female Fertility Hormone Test Type, Male Fertility Test Type and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 247: Rest of Asia-Pacific 13-Year Perspective for Fertility Testing by Test Type - Percentage Breakdown of Value Sales for Ovulation Prediction Test Type, Female Fertility Hormone Test Type, Male Fertility Test Type and Other Test Types for the Years 2020, 2026 & 2032
    • TABLE 248: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Fertility Testing by Sample - Urine-based Sample, Saliva-based Sample, Blood-based Sample and Semen-based Sample - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 249: Rest of Asia-Pacific Historic Review for Fertility Testing by Sample - Urine-based Sample, Saliva-based Sample, Blood-based Sample and Semen-based Sample Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 250: Rest of Asia-Pacific 13-Year Perspective for Fertility Testing by Sample - Percentage Breakdown of Value Sales for Urine-based Sample, Saliva-based Sample, Blood-based Sample and Semen-based Sample for the Years 2020, 2026 & 2032
    • TABLE 251: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Fertility Testing by Application - Female Fertility Testing Application and Male Fertility Testing Application - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 252: Rest of Asia-Pacific Historic Review for Fertility Testing by Application - Female Fertility Testing Application and Male Fertility Testing Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 253: Rest of Asia-Pacific 13-Year Perspective for Fertility Testing by Application - Percentage Breakdown of Value Sales for Female Fertility Testing Application and Male Fertility Testing Application for the Years 2020, 2026 & 2032
    • TABLE 254: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Fertility Testing by End-Use - Home Care Settings End-Use, Hospitals End-Use, Fertility Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 255: Rest of Asia-Pacific Historic Review for Fertility Testing by End-Use - Home Care Settings End-Use, Hospitals End-Use, Fertility Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 256: Rest of Asia-Pacific 13-Year Perspective for Fertility Testing by End-Use - Percentage Breakdown of Value Sales for Home Care Settings End-Use, Hospitals End-Use, Fertility Clinics End-Use and Other End-Uses for the Years 2020, 2026 & 2032
  • LATIN AMERICA
    • Fertility Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2026 (E)
    • TABLE 257: Latin America Recent Past, Current & Future Analysis for Fertility Testing by Application - Female Fertility Testing Application and Male Fertility Testing Application - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 258: Latin America Historic Review for Fertility Testing by Application - Female Fertility Testing Application and Male Fertility Testing Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 259: Latin America 13-Year Perspective for Fertility Testing by Application - Percentage Breakdown of Value Sales for Female Fertility Testing Application and Male Fertility Testing Application for the Years 2020, 2026 & 2032
    • TABLE 260: Latin America Recent Past, Current & Future Analysis for Fertility Testing by End-Use - Home Care Settings End-Use, Hospitals End-Use, Fertility Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 261: Latin America Historic Review for Fertility Testing by End-Use - Home Care Settings End-Use, Hospitals End-Use, Fertility Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 262: Latin America 13-Year Perspective for Fertility Testing by End-Use - Percentage Breakdown of Value Sales for Home Care Settings End-Use, Hospitals End-Use, Fertility Clinics End-Use and Other End-Uses for the Years 2020, 2026 & 2032
    • TABLE 263: Latin America Recent Past, Current & Future Analysis for Fertility Testing by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
    • TABLE 264: Latin America Historic Review for Fertility Testing by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 265: Latin America 13-Year Perspective for Fertility Testing by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2020, 2026 & 2032
    • TABLE 266: Latin America Recent Past, Current & Future Analysis for Fertility Testing by Test Type - Ovulation Prediction Test Type, Female Fertility Hormone Test Type, Male Fertility Test Type and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 267: Latin America Historic Review for Fertility Testing by Test Type - Ovulation Prediction Test Type, Female Fertility Hormone Test Type, Male Fertility Test Type and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 268: Latin America 13-Year Perspective for Fertility Testing by Test Type - Percentage Breakdown of Value Sales for Ovulation Prediction Test Type, Female Fertility Hormone Test Type, Male Fertility Test Type and Other Test Types for the Years 2020, 2026 & 2032
    • TABLE 269: Latin America Recent Past, Current & Future Analysis for Fertility Testing by Sample - Urine-based Sample, Saliva-based Sample, Blood-based Sample and Semen-based Sample - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 270: Latin America Historic Review for Fertility Testing by Sample - Urine-based Sample, Saliva-based Sample, Blood-based Sample and Semen-based Sample Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 271: Latin America 13-Year Perspective for Fertility Testing by Sample - Percentage Breakdown of Value Sales for Urine-based Sample, Saliva-based Sample, Blood-based Sample and Semen-based Sample for the Years 2020, 2026 & 2032
  • ARGENTINA
    • TABLE 272: Argentina Recent Past, Current & Future Analysis for Fertility Testing by Application - Female Fertility Testing Application and Male Fertility Testing Application - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 273: Argentina Historic Review for Fertility Testing by Application - Female Fertility Testing Application and Male Fertility Testing Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 274: Argentina 13-Year Perspective for Fertility Testing by Application - Percentage Breakdown of Value Sales for Female Fertility Testing Application and Male Fertility Testing Application for the Years 2020, 2026 & 2032
    • TABLE 275: Argentina Recent Past, Current & Future Analysis for Fertility Testing by End-Use - Home Care Settings End-Use, Hospitals End-Use, Fertility Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 276: Argentina Historic Review for Fertility Testing by End-Use - Home Care Settings End-Use, Hospitals End-Use, Fertility Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 277: Argentina 13-Year Perspective for Fertility Testing by End-Use - Percentage Breakdown of Value Sales for Home Care Settings End-Use, Hospitals End-Use, Fertility Clinics End-Use and Other End-Uses for the Years 2020, 2026 & 2032
    • TABLE 278: Argentina Recent Past, Current & Future Analysis for Fertility Testing by Test Type - Ovulation Prediction Test Type, Female Fertility Hormone Test Type, Male Fertility Test Type and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 279: Argentina Historic Review for Fertility Testing by Test Type - Ovulation Prediction Test Type, Female Fertility Hormone Test Type, Male Fertility Test Type and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 280: Argentina 13-Year Perspective for Fertility Testing by Test Type - Percentage Breakdown of Value Sales for Ovulation Prediction Test Type, Female Fertility Hormone Test Type, Male Fertility Test Type and Other Test Types for the Years 2020, 2026 & 2032
    • TABLE 281: Argentina Recent Past, Current & Future Analysis for Fertility Testing by Sample - Urine-based Sample, Saliva-based Sample, Blood-based Sample and Semen-based Sample - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 282: Argentina Historic Review for Fertility Testing by Sample - Urine-based Sample, Saliva-based Sample, Blood-based Sample and Semen-based Sample Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 283: Argentina 13-Year Perspective for Fertility Testing by Sample - Percentage Breakdown of Value Sales for Urine-based Sample, Saliva-based Sample, Blood-based Sample and Semen-based Sample for the Years 2020, 2026 & 2032
  • BRAZIL
    • TABLE 284: Brazil Recent Past, Current & Future Analysis for Fertility Testing by Application - Female Fertility Testing Application and Male Fertility Testing Application - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 285: Brazil Historic Review for Fertility Testing by Application - Female Fertility Testing Application and Male Fertility Testing Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 286: Brazil 13-Year Perspective for Fertility Testing by Application - Percentage Breakdown of Value Sales for Female Fertility Testing Application and Male Fertility Testing Application for the Years 2020, 2026 & 2032
    • TABLE 287: Brazil Recent Past, Current & Future Analysis for Fertility Testing by End-Use - Home Care Settings End-Use, Hospitals End-Use, Fertility Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 288: Brazil Historic Review for Fertility Testing by End-Use - Home Care Settings End-Use, Hospitals End-Use, Fertility Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 289: Brazil 13-Year Perspective for Fertility Testing by End-Use - Percentage Breakdown of Value Sales for Home Care Settings End-Use, Hospitals End-Use, Fertility Clinics End-Use and Other End-Uses for the Years 2020, 2026 & 2032
    • TABLE 290: Brazil Recent Past, Current & Future Analysis for Fertility Testing by Test Type - Ovulation Prediction Test Type, Female Fertility Hormone Test Type, Male Fertility Test Type and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 291: Brazil Historic Review for Fertility Testing by Test Type - Ovulation Prediction Test Type, Female Fertility Hormone Test Type, Male Fertility Test Type and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 292: Brazil 13-Year Perspective for Fertility Testing by Test Type - Percentage Breakdown of Value Sales for Ovulation Prediction Test Type, Female Fertility Hormone Test Type, Male Fertility Test Type and Other Test Types for the Years 2020, 2026 & 2032
    • TABLE 293: Brazil Recent Past, Current & Future Analysis for Fertility Testing by Sample - Urine-based Sample, Saliva-based Sample, Blood-based Sample and Semen-based Sample - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 294: Brazil Historic Review for Fertility Testing by Sample - Urine-based Sample, Saliva-based Sample, Blood-based Sample and Semen-based Sample Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 295: Brazil 13-Year Perspective for Fertility Testing by Sample - Percentage Breakdown of Value Sales for Urine-based Sample, Saliva-based Sample, Blood-based Sample and Semen-based Sample for the Years 2020, 2026 & 2032
  • MEXICO
    • TABLE 296: Mexico Recent Past, Current & Future Analysis for Fertility Testing by Application - Female Fertility Testing Application and Male Fertility Testing Application - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 297: Mexico Historic Review for Fertility Testing by Application - Female Fertility Testing Application and Male Fertility Testing Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 298: Mexico 13-Year Perspective for Fertility Testing by Application - Percentage Breakdown of Value Sales for Female Fertility Testing Application and Male Fertility Testing Application for the Years 2020, 2026 & 2032
    • TABLE 299: Mexico Recent Past, Current & Future Analysis for Fertility Testing by End-Use - Home Care Settings End-Use, Hospitals End-Use, Fertility Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 300: Mexico Historic Review for Fertility Testing by End-Use - Home Care Settings End-Use, Hospitals End-Use, Fertility Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 301: Mexico 13-Year Perspective for Fertility Testing by End-Use - Percentage Breakdown of Value Sales for Home Care Settings End-Use, Hospitals End-Use, Fertility Clinics End-Use and Other End-Uses for the Years 2020, 2026 & 2032
    • TABLE 302: Mexico Recent Past, Current & Future Analysis for Fertility Testing by Test Type - Ovulation Prediction Test Type, Female Fertility Hormone Test Type, Male Fertility Test Type and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 303: Mexico Historic Review for Fertility Testing by Test Type - Ovulation Prediction Test Type, Female Fertility Hormone Test Type, Male Fertility Test Type and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 304: Mexico 13-Year Perspective for Fertility Testing by Test Type - Percentage Breakdown of Value Sales for Ovulation Prediction Test Type, Female Fertility Hormone Test Type, Male Fertility Test Type and Other Test Types for the Years 2020, 2026 & 2032
    • TABLE 305: Mexico Recent Past, Current & Future Analysis for Fertility Testing by Sample - Urine-based Sample, Saliva-based Sample, Blood-based Sample and Semen-based Sample - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 306: Mexico Historic Review for Fertility Testing by Sample - Urine-based Sample, Saliva-based Sample, Blood-based Sample and Semen-based Sample Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 307: Mexico 13-Year Perspective for Fertility Testing by Sample - Percentage Breakdown of Value Sales for Urine-based Sample, Saliva-based Sample, Blood-based Sample and Semen-based Sample for the Years 2020, 2026 & 2032
  • REST OF LATIN AMERICA
    • TABLE 308: Rest of Latin America Recent Past, Current & Future Analysis for Fertility Testing by Application - Female Fertility Testing Application and Male Fertility Testing Application - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 309: Rest of Latin America Historic Review for Fertility Testing by Application - Female Fertility Testing Application and Male Fertility Testing Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 310: Rest of Latin America 13-Year Perspective for Fertility Testing by Application - Percentage Breakdown of Value Sales for Female Fertility Testing Application and Male Fertility Testing Application for the Years 2020, 2026 & 2032
    • TABLE 311: Rest of Latin America Recent Past, Current & Future Analysis for Fertility Testing by End-Use - Home Care Settings End-Use, Hospitals End-Use, Fertility Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 312: Rest of Latin America Historic Review for Fertility Testing by End-Use - Home Care Settings End-Use, Hospitals End-Use, Fertility Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 313: Rest of Latin America 13-Year Perspective for Fertility Testing by End-Use - Percentage Breakdown of Value Sales for Home Care Settings End-Use, Hospitals End-Use, Fertility Clinics End-Use and Other End-Uses for the Years 2020, 2026 & 2032
    • TABLE 314: Rest of Latin America Recent Past, Current & Future Analysis for Fertility Testing by Test Type - Ovulation Prediction Test Type, Female Fertility Hormone Test Type, Male Fertility Test Type and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 315: Rest of Latin America Historic Review for Fertility Testing by Test Type - Ovulation Prediction Test Type, Female Fertility Hormone Test Type, Male Fertility Test Type and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 316: Rest of Latin America 13-Year Perspective for Fertility Testing by Test Type - Percentage Breakdown of Value Sales for Ovulation Prediction Test Type, Female Fertility Hormone Test Type, Male Fertility Test Type and Other Test Types for the Years 2020, 2026 & 2032
    • TABLE 317: Rest of Latin America Recent Past, Current & Future Analysis for Fertility Testing by Sample - Urine-based Sample, Saliva-based Sample, Blood-based Sample and Semen-based Sample - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 318: Rest of Latin America Historic Review for Fertility Testing by Sample - Urine-based Sample, Saliva-based Sample, Blood-based Sample and Semen-based Sample Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 319: Rest of Latin America 13-Year Perspective for Fertility Testing by Sample - Percentage Breakdown of Value Sales for Urine-based Sample, Saliva-based Sample, Blood-based Sample and Semen-based Sample for the Years 2020, 2026 & 2032
  • MIDDLE EAST
    • Fertility Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2026 (E)
    • TABLE 320: Middle East Recent Past, Current & Future Analysis for Fertility Testing by Application - Female Fertility Testing Application and Male Fertility Testing Application - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 321: Middle East Historic Review for Fertility Testing by Application - Female Fertility Testing Application and Male Fertility Testing Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 322: Middle East 13-Year Perspective for Fertility Testing by Application - Percentage Breakdown of Value Sales for Female Fertility Testing Application and Male Fertility Testing Application for the Years 2020, 2026 & 2032
    • TABLE 323: Middle East Recent Past, Current & Future Analysis for Fertility Testing by End-Use - Home Care Settings End-Use, Hospitals End-Use, Fertility Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 324: Middle East Historic Review for Fertility Testing by End-Use - Home Care Settings End-Use, Hospitals End-Use, Fertility Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 325: Middle East 13-Year Perspective for Fertility Testing by End-Use - Percentage Breakdown of Value Sales for Home Care Settings End-Use, Hospitals End-Use, Fertility Clinics End-Use and Other End-Uses for the Years 2020, 2026 & 2032
    • TABLE 326: Middle East Recent Past, Current & Future Analysis for Fertility Testing by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
    • TABLE 327: Middle East Historic Review for Fertility Testing by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 328: Middle East 13-Year Perspective for Fertility Testing by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2020, 2026 & 2032
    • TABLE 329: Middle East Recent Past, Current & Future Analysis for Fertility Testing by Test Type - Ovulation Prediction Test Type, Female Fertility Hormone Test Type, Male Fertility Test Type and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 330: Middle East Historic Review for Fertility Testing by Test Type - Ovulation Prediction Test Type, Female Fertility Hormone Test Type, Male Fertility Test Type and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 331: Middle East 13-Year Perspective for Fertility Testing by Test Type - Percentage Breakdown of Value Sales for Ovulation Prediction Test Type, Female Fertility Hormone Test Type, Male Fertility Test Type and Other Test Types for the Years 2020, 2026 & 2032
    • TABLE 332: Middle East Recent Past, Current & Future Analysis for Fertility Testing by Sample - Urine-based Sample, Saliva-based Sample, Blood-based Sample and Semen-based Sample - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 333: Middle East Historic Review for Fertility Testing by Sample - Urine-based Sample, Saliva-based Sample, Blood-based Sample and Semen-based Sample Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 334: Middle East 13-Year Perspective for Fertility Testing by Sample - Percentage Breakdown of Value Sales for Urine-based Sample, Saliva-based Sample, Blood-based Sample and Semen-based Sample for the Years 2020, 2026 & 2032
  • IRAN
    • TABLE 335: Iran Recent Past, Current & Future Analysis for Fertility Testing by Application - Female Fertility Testing Application and Male Fertility Testing Application - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 336: Iran Historic Review for Fertility Testing by Application - Female Fertility Testing Application and Male Fertility Testing Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 337: Iran 13-Year Perspective for Fertility Testing by Application - Percentage Breakdown of Value Sales for Female Fertility Testing Application and Male Fertility Testing Application for the Years 2020, 2026 & 2032
    • TABLE 338: Iran Recent Past, Current & Future Analysis for Fertility Testing by End-Use - Home Care Settings End-Use, Hospitals End-Use, Fertility Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 339: Iran Historic Review for Fertility Testing by End-Use - Home Care Settings End-Use, Hospitals End-Use, Fertility Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 340: Iran 13-Year Perspective for Fertility Testing by End-Use - Percentage Breakdown of Value Sales for Home Care Settings End-Use, Hospitals End-Use, Fertility Clinics End-Use and Other End-Uses for the Years 2020, 2026 & 2032
    • TABLE 341: Iran Recent Past, Current & Future Analysis for Fertility Testing by Test Type - Ovulation Prediction Test Type, Female Fertility Hormone Test Type, Male Fertility Test Type and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 342: Iran Historic Review for Fertility Testing by Test Type - Ovulation Prediction Test Type, Female Fertility Hormone Test Type, Male Fertility Test Type and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 343: Iran 13-Year Perspective for Fertility Testing by Test Type - Percentage Breakdown of Value Sales for Ovulation Prediction Test Type, Female Fertility Hormone Test Type, Male Fertility Test Type and Other Test Types for the Years 2020, 2026 & 2032
    • TABLE 344: Iran Recent Past, Current & Future Analysis for Fertility Testing by Sample - Urine-based Sample, Saliva-based Sample, Blood-based Sample and Semen-based Sample - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 345: Iran Historic Review for Fertility Testing by Sample - Urine-based Sample, Saliva-based Sample, Blood-based Sample and Semen-based Sample Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 346: Iran 13-Year Perspective for Fertility Testing by Sample - Percentage Breakdown of Value Sales for Urine-based Sample, Saliva-based Sample, Blood-based Sample and Semen-based Sample for the Years 2020, 2026 & 2032
  • ISRAEL
    • TABLE 347: Israel Recent Past, Current & Future Analysis for Fertility Testing by Application - Female Fertility Testing Application and Male Fertility Testing Application - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 348: Israel Historic Review for Fertility Testing by Application - Female Fertility Testing Application and Male Fertility Testing Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 349: Israel 13-Year Perspective for Fertility Testing by Application - Percentage Breakdown of Value Sales for Female Fertility Testing Application and Male Fertility Testing Application for the Years 2020, 2026 & 2032
    • TABLE 350: Israel Recent Past, Current & Future Analysis for Fertility Testing by End-Use - Home Care Settings End-Use, Hospitals End-Use, Fertility Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 351: Israel Historic Review for Fertility Testing by End-Use - Home Care Settings End-Use, Hospitals End-Use, Fertility Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 352: Israel 13-Year Perspective for Fertility Testing by End-Use - Percentage Breakdown of Value Sales for Home Care Settings End-Use, Hospitals End-Use, Fertility Clinics End-Use and Other End-Uses for the Years 2020, 2026 & 2032
    • TABLE 353: Israel Recent Past, Current & Future Analysis for Fertility Testing by Test Type - Ovulation Prediction Test Type, Female Fertility Hormone Test Type, Male Fertility Test Type and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 354: Israel Historic Review for Fertility Testing by Test Type - Ovulation Prediction Test Type, Female Fertility Hormone Test Type, Male Fertility Test Type and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 355: Israel 13-Year Perspective for Fertility Testing by Test Type - Percentage Breakdown of Value Sales for Ovulation Prediction Test Type, Female Fertility Hormone Test Type, Male Fertility Test Type and Other Test Types for the Years 2020, 2026 & 2032
    • TABLE 356: Israel Recent Past, Current & Future Analysis for Fertility Testing by Sample - Urine-based Sample, Saliva-based Sample, Blood-based Sample and Semen-based Sample - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 357: Israel Historic Review for Fertility Testing by Sample - Urine-based Sample, Saliva-based Sample, Blood-based Sample and Semen-based Sample Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 358: Israel 13-Year Perspective for Fertility Testing by Sample - Percentage Breakdown of Value Sales for Urine-based Sample, Saliva-based Sample, Blood-based Sample and Semen-based Sample for the Years 2020, 2026 & 2032
  • SAUDI ARABIA
    • TABLE 359: Saudi Arabia Recent Past, Current & Future Analysis for Fertility Testing by Application - Female Fertility Testing Application and Male Fertility Testing Application - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 360: Saudi Arabia Historic Review for Fertility Testing by Application - Female Fertility Testing Application and Male Fertility Testing Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 361: Saudi Arabia 13-Year Perspective for Fertility Testing by Application - Percentage Breakdown of Value Sales for Female Fertility Testing Application and Male Fertility Testing Application for the Years 2020, 2026 & 2032
    • TABLE 362: Saudi Arabia Recent Past, Current & Future Analysis for Fertility Testing by End-Use - Home Care Settings End-Use, Hospitals End-Use, Fertility Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 363: Saudi Arabia Historic Review for Fertility Testing by End-Use - Home Care Settings End-Use, Hospitals End-Use, Fertility Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 364: Saudi Arabia 13-Year Perspective for Fertility Testing by End-Use - Percentage Breakdown of Value Sales for Home Care Settings End-Use, Hospitals End-Use, Fertility Clinics End-Use and Other End-Uses for the Years 2020, 2026 & 2032
    • TABLE 365: Saudi Arabia Recent Past, Current & Future Analysis for Fertility Testing by Test Type - Ovulation Prediction Test Type, Female Fertility Hormone Test Type, Male Fertility Test Type and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 366: Saudi Arabia Historic Review for Fertility Testing by Test Type - Ovulation Prediction Test Type, Female Fertility Hormone Test Type, Male Fertility Test Type and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 367: Saudi Arabia 13-Year Perspective for Fertility Testing by Test Type - Percentage Breakdown of Value Sales for Ovulation Prediction Test Type, Female Fertility Hormone Test Type, Male Fertility Test Type and Other Test Types for the Years 2020, 2026 & 2032
    • TABLE 368: Saudi Arabia Recent Past, Current & Future Analysis for Fertility Testing by Sample - Urine-based Sample, Saliva-based Sample, Blood-based Sample and Semen-based Sample - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 369: Saudi Arabia Historic Review for Fertility Testing by Sample - Urine-based Sample, Saliva-based Sample, Blood-based Sample and Semen-based Sample Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 370: Saudi Arabia 13-Year Perspective for Fertility Testing by Sample - Percentage Breakdown of Value Sales for Urine-based Sample, Saliva-based Sample, Blood-based Sample and Semen-based Sample for the Years 2020, 2026 & 2032
  • UNITED ARAB EMIRATES
    • TABLE 371: UAE Recent Past, Current & Future Analysis for Fertility Testing by Application - Female Fertility Testing Application and Male Fertility Testing Application - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 372: UAE Historic Review for Fertility Testing by Application - Female Fertility Testing Application and Male Fertility Testing Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 373: UAE 13-Year Perspective for Fertility Testing by Application - Percentage Breakdown of Value Sales for Female Fertility Testing Application and Male Fertility Testing Application for the Years 2020, 2026 & 2032
    • TABLE 374: UAE Recent Past, Current & Future Analysis for Fertility Testing by End-Use - Home Care Settings End-Use, Hospitals End-Use, Fertility Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 375: UAE Historic Review for Fertility Testing by End-Use - Home Care Settings End-Use, Hospitals End-Use, Fertility Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 376: UAE 13-Year Perspective for Fertility Testing by End-Use - Percentage Breakdown of Value Sales for Home Care Settings End-Use, Hospitals End-Use, Fertility Clinics End-Use and Other End-Uses for the Years 2020, 2026 & 2032
    • TABLE 377: UAE Recent Past, Current & Future Analysis for Fertility Testing by Test Type - Ovulation Prediction Test Type, Female Fertility Hormone Test Type, Male Fertility Test Type and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 378: UAE Historic Review for Fertility Testing by Test Type - Ovulation Prediction Test Type, Female Fertility Hormone Test Type, Male Fertility Test Type and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 379: UAE 13-Year Perspective for Fertility Testing by Test Type - Percentage Breakdown of Value Sales for Ovulation Prediction Test Type, Female Fertility Hormone Test Type, Male Fertility Test Type and Other Test Types for the Years 2020, 2026 & 2032
    • TABLE 380: UAE Recent Past, Current & Future Analysis for Fertility Testing by Sample - Urine-based Sample, Saliva-based Sample, Blood-based Sample and Semen-based Sample - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 381: UAE Historic Review for Fertility Testing by Sample - Urine-based Sample, Saliva-based Sample, Blood-based Sample and Semen-based Sample Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 382: UAE 13-Year Perspective for Fertility Testing by Sample - Percentage Breakdown of Value Sales for Urine-based Sample, Saliva-based Sample, Blood-based Sample and Semen-based Sample for the Years 2020, 2026 & 2032
  • REST OF MIDDLE EAST
    • TABLE 383: Rest of Middle East Recent Past, Current & Future Analysis for Fertility Testing by Application - Female Fertility Testing Application and Male Fertility Testing Application - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 384: Rest of Middle East Historic Review for Fertility Testing by Application - Female Fertility Testing Application and Male Fertility Testing Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 385: Rest of Middle East 13-Year Perspective for Fertility Testing by Application - Percentage Breakdown of Value Sales for Female Fertility Testing Application and Male Fertility Testing Application for the Years 2020, 2026 & 2032
    • TABLE 386: Rest of Middle East Recent Past, Current & Future Analysis for Fertility Testing by End-Use - Home Care Settings End-Use, Hospitals End-Use, Fertility Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 387: Rest of Middle East Historic Review for Fertility Testing by End-Use - Home Care Settings End-Use, Hospitals End-Use, Fertility Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 388: Rest of Middle East 13-Year Perspective for Fertility Testing by End-Use - Percentage Breakdown of Value Sales for Home Care Settings End-Use, Hospitals End-Use, Fertility Clinics End-Use and Other End-Uses for the Years 2020, 2026 & 2032
    • TABLE 389: Rest of Middle East Recent Past, Current & Future Analysis for Fertility Testing by Test Type - Ovulation Prediction Test Type, Female Fertility Hormone Test Type, Male Fertility Test Type and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 390: Rest of Middle East Historic Review for Fertility Testing by Test Type - Ovulation Prediction Test Type, Female Fertility Hormone Test Type, Male Fertility Test Type and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 391: Rest of Middle East 13-Year Perspective for Fertility Testing by Test Type - Percentage Breakdown of Value Sales for Ovulation Prediction Test Type, Female Fertility Hormone Test Type, Male Fertility Test Type and Other Test Types for the Years 2020, 2026 & 2032
    • TABLE 392: Rest of Middle East Recent Past, Current & Future Analysis for Fertility Testing by Sample - Urine-based Sample, Saliva-based Sample, Blood-based Sample and Semen-based Sample - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 393: Rest of Middle East Historic Review for Fertility Testing by Sample - Urine-based Sample, Saliva-based Sample, Blood-based Sample and Semen-based Sample Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 394: Rest of Middle East 13-Year Perspective for Fertility Testing by Sample - Percentage Breakdown of Value Sales for Urine-based Sample, Saliva-based Sample, Blood-based Sample and Semen-based Sample for the Years 2020, 2026 & 2032
  • AFRICA
    • Fertility Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2026 (E)
    • TABLE 395: Africa Recent Past, Current & Future Analysis for Fertility Testing by Application - Female Fertility Testing Application and Male Fertility Testing Application - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 396: Africa Historic Review for Fertility Testing by Application - Female Fertility Testing Application and Male Fertility Testing Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 397: Africa 13-Year Perspective for Fertility Testing by Application - Percentage Breakdown of Value Sales for Female Fertility Testing Application and Male Fertility Testing Application for the Years 2020, 2026 & 2032
    • TABLE 398: Africa Recent Past, Current & Future Analysis for Fertility Testing by End-Use - Home Care Settings End-Use, Hospitals End-Use, Fertility Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 399: Africa Historic Review for Fertility Testing by End-Use - Home Care Settings End-Use, Hospitals End-Use, Fertility Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 400: Africa 13-Year Perspective for Fertility Testing by End-Use - Percentage Breakdown of Value Sales for Home Care Settings End-Use, Hospitals End-Use, Fertility Clinics End-Use and Other End-Uses for the Years 2020, 2026 & 2032
    • TABLE 401: Africa Recent Past, Current & Future Analysis for Fertility Testing by Test Type - Ovulation Prediction Test Type, Female Fertility Hormone Test Type, Male Fertility Test Type and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 402: Africa Historic Review for Fertility Testing by Test Type - Ovulation Prediction Test Type, Female Fertility Hormone Test Type, Male Fertility Test Type and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 403: Africa 13-Year Perspective for Fertility Testing by Test Type - Percentage Breakdown of Value Sales for Ovulation Prediction Test Type, Female Fertility Hormone Test Type, Male Fertility Test Type and Other Test Types for the Years 2020, 2026 & 2032
    • TABLE 404: Africa Recent Past, Current & Future Analysis for Fertility Testing by Sample - Urine-based Sample, Saliva-based Sample, Blood-based Sample and Semen-based Sample - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 405: Africa Historic Review for Fertility Testing by Sample - Urine-based Sample, Saliva-based Sample, Blood-based Sample and Semen-based Sample Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 406: Africa 13-Year Perspective for Fertility Testing by Sample - Percentage Breakdown of Value Sales for Urine-based Sample, Saliva-based Sample, Blood-based Sample and Semen-based Sample for the Years 2020, 2026 & 2032

IV. COMPETITION

×

원하시는 정보를 찾아 드릴까요?

보안문자 새로고침
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제
문의
원하시는 정보를
찾아 드릴까요?
문의주시면 필요한 정보를
신속하게 찾아드릴게요.
02-2025-2992
email
문의하기